Hamilton Scale: Hamilton Depression Rating Scale score
BDI Score: Beck Depression Inventory Score
Alcohol Drinks per Week: Alcohol use behaviors measured by drinks per week
CES-D: Center for Epidemiologic Studies-Depression Scale
HRSD: Hamilton Rating Scale for Depression (17‑item version)
SIGH-D: Structured Interview Guide for the Hamilton Depression Rating Scale
Number of Adverse Events: Count of adverse events emerging or worsening during treatment
IDS-C: Inventory of Depressive Symptomatology – Clinician Rated score
BDI-II: Beck Depression Inventory II score
PANAS-NA: Negative Affect subscale of the Positive and Negative Affect Schedule
HAM-D: Hamilton Depression Scale score
DSM-IV MDD Diagnosis: Does not meet DSM-IV criteria for Major Depressive Disorder
PSR: Problem Symptom Rating (LIFE)
HRSD: Hamilton Rating Scale for Depression
SAE: Serious Adverse Event
BDI: Beck Depression Inventory
MOSBPI: Mean change in Medical Outcomes Survey-Version 1 Bodily Pain Index score
MOSPCS: Mean change in Medical Outcomes Survey-Version 1 Physical Component Score
MOSMCS: Mean change in Medical Outcomes Survey-Version 1 Mental Component Score
HAMD: Hamilton Depression Rating Scale score
HAMD Response Count: Number of participants with ≥50% reduction in HAMD and final score <10
IDS-C30 Score: Inventory for Depressive Symptomatology- Clinician-rated score
Remission Rate: Percentage of participants achieving IDS-C30 ≤12
MMSE: Mini Mental State Examination
GDS: Geriatric Depression Scale
HAM-D: Hamilton Depression Rating Scale
MADRS: Montgomery-Asberg Depression Rating Scale
HAM-D: Hamilton Depression Rating Scale 17-item
Remission Proportion: Proportion of participants achieving a final HAM‑D score of 7 or less
Response Proportion: Proportion of participants achieving a 50 percent or greater reduction in HAM‑D score
HAM-D: Hamilton Depression Rating Scale Score
MADRS: Montgomery-Åsberg Depression Rating Scale
LIFE-PSR: Longitudinal Interval Follow‑up Evaluation – Psychiatric Status Rating score ≥5 for 2 consecutive weeks
Kaplan-Meier: Kaplan‑Meier estimate of relapse/recurrence rate
MADRS: Montgomery-Åsberg Depression Rating Scale score
HAM-D: Hamilton Depression Rating Scale score
AR: Abstinence Response (dichotomous variable based on two consecutive urine‑confirmed abstinent weeks)
SRMU: Self‑Reported Marijuana Use (negative) per Timeline FollowBack
UTN: Urine THC Negative (urine sample testing negative for THC)
PCR Negativity: Negative Polymerase Chain Reaction result
MADRS: Montgomery‑Åsberg Depression Rating Scale
Patients Without Clinically Relevant Depression: Number of patients who never achieved a MADRS score of 13 or higher
Percentage of Participants with Clinically Relevant Depression: Proportion of participants with a MADRS score >13
HRS: Hamilton Rating Scale for Depression Score
Remission Threshold: HRS score ≤8
HRSD: Hamilton Rating Scale for Depression
HAMD-17: Hamilton Depression Rating Scale 17-item
RESP: Clinical Responder status (>50% improvement in HAMD-17)
REM: Clinical Remission status (<8 HAMD-17 score at endpoint)
Cumulative Incidence: Cumulative incidence over 12 weeks of follow‑up
HAM-D: Hamilton Depression Rating Scale
FIM Motor Subscale: Functional Independence Measure 13‑item motor subscale
HAMD: Hamilton Depression Rating Scale
HAM-D-17: Hamilton Depression Rating Scale 17‑item severity score
HAM-D-17 Response: 50% decrease in HAM‑D‑17 score
HAM-D-17 Remission: score ≤7
CPAS: California Pharmacotherapy Alliance Scale 24‑item questionnaire
PHQ-9: Patient Health Questionnaire‑9 score
Ham-D: Hamilton Depression Rating Scale score
MDE: Presence of Major Depressive Episode (binary outcome)
Life-3: Single-item Quality of Life measure
BAI: Beck Anxiety Inventory score
DSM-IV: Diagnostic and Statistical Manual IV diagnosis of depression
HAM-D: Hamilton Rating Scale for Depression score
SPID: Structured Psychiatric Interview for Depression
DSRS: Depression Symptom Rating Scale
IL-28B: Interleukin‑28B Gene Polymorphism (c/c, c/t, t/t)
Pro‑Inflammatory Cytokine: Pro‑inflammatory Cytokine Concentration
Serotonin: Serum Serotonin Concentration
HDRS: Hamilton Depression Scale
CGI-S: Global Severity rating (scale 1-7)
CGI-I: Global Improvement rating (scale 1-7)
HAM-D: Hamilton Depression Rating Scale total score (0-52)
QIDS-C: percent of remitters on the 16‑item Inventory of Depressive Symptomatology – clinician rated
QIDS-C: percent of responders on the 16‑item Inventory of Depressive Symptomatology – clinician rated
QIDS-C: mean percent change on the 16‑item Inventory of Depressive Symptomatology – clinician rated
QIDS-C: mean change on the 16‑item Inventory of Depressive Symptomatology – clinician rated
CGI-I: Clinical Global Impressions‑Improvement scale
IDS-C: percent of remitters on the 30‑item Inventory of Depressive Symptomatology – clinician rated
IDS-C: percent of responders on the 30‑item Inventory of Depressive Symptomatology – clinician rated
IDS-C: mean percent change on the 30‑item Inventory of Depressive Symptomatology – clinician rated
IDS-C: mean change on the 30‑item Inventory of Depressive Symptomatology – clinician rated
IDS-SR: percent of remitters on the 30‑item Inventory of Depressive Symptomatology – self‑report
IDS-SR: percent of responders on the 30‑item Inventory of Depressive Symptomatology – self‑report
IDS-SR: mean percent change on the 30‑item Inventory of Depressive Symptomatology – self‑report
IDS-SR: mean change on the 30‑item Inventory of Depressive Symptomatology – self‑report
MADRS: percent of remitters on the Montgomery‑Åsberg Depression Rating Scale
MADRS: percent of responders on the Montgomery‑Åsberg Depression Rating Scale
MADRS: mean percent change on the Montgomery‑Åsberg Depression Rating Scale
MADRS: mean change on the Montgomery‑Åsberg Depression Rating Scale
SR: Sustained Response percentage of acute phase responders remaining responsive at week 50
17SCALE: 17‑item scale used to assess depression severity with total score 17–113
IMP-SCALE: 7‑point clinician‑rated improvement/worsening scale
CES-D: Center for Epidemiological Studies - Depression Scale
HAM-D Score: Hamilton Depression Rating Scale total score
Remission Rate: Percentage of participants with HAM-D <7
Response Rate: Percentage of participants with ≥50% reduction in HAM-D
GDS: Geriatric Depression Scale
SCID: Structured Clinical Interview for DSM-IV
Cortisol Concentration: Plasma Concentration of Cortisol Hormone
IL-2 Doses Tolerated: Mean Number of IL-2 Doses Tolerated
HAM-D: Hamilton Depression Rating Scale Score
ACTH Concentration: Plasma Concentration of Adrenocorticotropic Hormone
IL-6 Concentration: Plasma Concentration of Interleukin 6
MEMS Adherence Index: Percentage of days medication container opened
BDI-II Score: Total score of Beck Depression Inventory II
HDRS: Hamilton Depression Rating Scale score
REM: Remission Status (HDRS score ≥7)
NR: Non-response (<30% reduction from baseline)
PR: Partial Response (30‑49% reduction from baseline)
RW: Response without remission (>50% reduction from baseline & HDRS‑17 >7)
REC: Recurrence of Depression (number of participants experiencing recurrence after remission)
PER_REM: Percentage of participants achieving remission (overall, at 10 weeks, at 12 weeks)
COMB_REM: Number of participants achieving remission after 12 weeks of combined antidepressant + CBT
SDS: Sheehan Disability Scale
HAM-D: Hamilton Depression Rating Scale
MADRS: Montgomery Asberg Depression Scale
WHODAS-II: WHO Disability Assessment Schedule II
HAM-D17: Hamilton Psychiatric Rating Scale for Depression 17-item score
HAM-A: Hamilton Anxiety Rating Scale 14-item score
EQ-5D Summary Index: Health outcome index 0-1
CGI-I: Clinical Global Impressions – Improvement scale 1-7
DESS: Discontinuation‑Emergent Symptom Scale total score 0-43
GCI-I: Global Clinical Impression – Improvement score
ASEX: Arizona Sexual Experiences Scale score
IDS-C: Inventory of Depressive Symptoms – Clinician Rated score
EQ-5D: EuroQoL Five Dimensions health outcome index
HAM-D17: Hamilton Psychiatric Rating Scale for Depression score
CGI-S: Clinical Global Impressions – Severity score
CGI-I: Clinical Global Impressions – Improvement score
HAM-A: Hamilton Anxiety Rating Scale score
DESS: Discontinuation‑Emergent Symptom Scale total score
MADRS: Montgomery-Asberg Depression Rating Scale
SSI: Beck Scale for Suicidal Ideation score
COPE: Percent change in contrast of parameter estimates measured during Monetary Incentive Delay Task
Impulsivity Change: Change in neuropsychological measure of impulsivity
Suicidal Behavior Events: Occurrence of suicide attempts, other suicidal behavior, or increase in suicidal thoughts requiring treatment change
CSHF: Columbia Suicide History Form
SSI: Scale for Suicidal Ideation Score
HDRS: 24‑item Hamilton Depression Rating Scale
PI: Percent improvement from baseline to end of treatment using HDRS
REM: Remission status defined by ≥50% decrease in HDRS and final HDRS <10
Sleep Efficiency: Percentage of time in bed spent sleeping
hs-CRP Concentration: High‑sensitivity C‑reactive protein level (mg/L)
CRP Concentration: C‑reactive protein level (mg/L)
HDRS Score: Hamilton Depression Rating Scale total score
HDRS Change: Least squares mean change in HDRS score from baseline to week 12
HDRS 50% Reduction: Number of participants with ≥50% reduction in HDRS scores
HDRS Remission: Number of participants achieving remission (HDRS ≤7 or CGI‑I=1)
IL-6 Concentration: Interleukin‑6 level (pg/mL)
CGI‑I Score: Clinical Global Impression‑Improvement score
IDS‑SR Score: Inventory of Depressive Symptomatology Self‑Report total score
HbA1c: Hemoglobin A1c
SCL-20: 20-question Checklist for Depression Symptoms
LDL: Low Density Lipoprotein Cholesterol
SBP: Systolic Blood Pressure
Sheehan Disability Scale: Average Disability Score
HDRS: Hamilton Depression Rating Scale
MADRS: Montgomery‑Asberg Depression Rating Scale
Missed Buprenorphine Doses: Number of missed buprenorphine doses over 7 days
BDI-II: Beck Depression Inventory II score
HRS: Hamilton Rating Scale for Depression (24-question version)
HDRS Threshold: HDRS score <10 sustained for 2 weeks
Stable Remission Count: Number of participants achieving HDRS <10 for 2 weeks
SF-20: Medical Outcomes Study Short Form 20 Physical Functioning Composite Score
PHQ-9: Primary Care Evaluation of Mental Disorders Patient Health Questionnaire-9
BDI-II: Beck Depression Inventory, 2nd Edition total score
Medication Adherence: Antidepressant medication adherence status
Depression Prevention Stage: Classification of participants into precontemplation, contemplation, preparation, action, or maintenance
PHQ-9: Patient Health Questionnaire 9-item depression scale
HAM-D: Hamilton Depression Rating Scale
Number of session: Total number of therapy sessions attended
Drop-out rate: Participants who dropped out of therapy
DRS: Standard 17-item rating scale for depression
QIDS-SR-16: Quick Inventory of Depressive Symptomatology – Self Report 16-item total score
Participants Meeting Threshold: Number of participants achieving QIDS‑SR‑16 ≥11
HAM-D: Hamilton Depression Rating Scale
Heavy Drinking Days Count: Number of heavy drinking days
Drinking Days Count: Number of drinking days
Percentage of Heavy Drinking Days: Proportion of heavy drinking days over total study days
Percentage of Drinking Days: Proportion of drinking days over total study days
ATTENDANCE: Attendance at first depression treatment appointment (yes/no)
TIME TO FIRST SESSION: Average time to attendance at first session (weeks)
CES-D: Center for Epidemiologic Studies‑Depression Scale Score
7DPPA: 7‑Day Point Prevalence Abstinence
CAVLT-2: Children's Auditory Verbal Learning Test 2 score (normalized standard score)
CDRS-R: Children's Depression Rating Scale, Revised score
Q-LES-Q-SF: Quality of Life Enjoyment and Satisfaction Questionnaire – Short Form score
HDRS: Hamilton Depression Rating Scale score
ENG: Engagement status defined as at least one visit with a mental health provider within 12 or 24 weeks
BDW: Mean number of binge days per week
WFE: Weekly frequency of binge episodes after baseline
MADRS: 10‑item scale assessing severity of depression (score range 0–60)
CDRS-R: Children’s Depression Rating Scale – Revised score used to define remission (≤28) and relapse (≥40 or <40 with deterioration)
K-Life: Weekly K‑Life interview rating scale (1–6) used to assess depression severity and relapse
Time Well: Weeks with a K‑Life rating of 1 or 2 indicating minimal symptoms
Percent Time Well: Proportion of weeks with a K‑Life rating of 1 or 2 relative to total study weeks
IDS-C30 Score: Inventory of Depressive Symptomology – Clinician rating total score
IDS-SR30 Score: Inventory of Depressive Symptomology – Self Report total score
MADRS Score: Montgomery and Åsberg Depression Rating Scale total score
WSAS Score: Work and Social Adjustment Scale total score
Q-LES-Q Score: Quality of Life Enjoyment and Satisfaction Questionnaire total score
QIDS-SR Score: Quick Inventory of Depressive Symptomatology – Self Report total score
GAF Score: Global Assessment Scale total score
HDRS-17 Score: Hamilton Rating Scale for Depression 17‑item total score
AUC: Area Under Curve (plasma concentration‑time)
CDRS-R: Clinical Depression Rating Scale – Revised total score
CGI-S: Clinical Global Impression – Severity scale
Plasma Half-Life: Time for plasma concentration to halve
HAM-D: Hamilton Depression Rating Scale total score
CGI-I: Clinical Global Impression – Improvement scale
AE: Adverse Event occurrence
SAE: Serious Adverse Event occurrence
Number of Participants: Count of study subjects
No Adverse Events: Reported lack of adverse events
CORD: Cordance intensity value Z(s,f)
THETA-CORD: Theta‑band cordance (8‑12 Hz) in prefrontal region
ANORM: Absolute power z‑score (Anorm(s,f))
RNORM: Relative power z‑score (Rnorm(s,f))
HAM-A: Hamilton Anxiety Rating Scale
HAM-D: Hamilton Depression Rating Scale
BDI: Beck Depression Inventory
SCLPR: SCL Percent Reduction (50% reduction in SCL depression score)
IPAQCH: IPAQ Change (mean change from baseline)
DWCH: Days Walk Change (mean change in days walk per week)
QT%: Quit Attempt Percentage (intentional cessation ≥24h)
ABST%: Abstinence Percentage (self‑reported 7‑day point prevalence abstinence)
CPDCH: Cigarettes Per Day Change (mean change in cigarettes smoked per day)
HAMD-17 Sleep Subscale: Evaluation of insomnia via HAMD‑17 items 4,5,6
DBP Change: Mean change from baseline to endpoint in diastolic blood pressure
PR Change: Mean change from baseline to endpoint in pulse rate
SDS: Sheehan Disability Scale assessing work/school, social, and family domains
GFIS: Global Functional Impairment Score derived from SDS
WC: Mean change from baseline to endpoint in weight
HAMD-17 Total Score: Rater‑administered depression severity
WP: Work Productivity Score calculated from income and hours
WPA: Work Productivity Assessment tool measuring impact of depressive symptoms on work
LWP: Lost Work Performance combining absenteeism and presenteeism
SBP Change: Mean change from baseline to endpoint in systolic blood pressure
HAMD-17 RR: Response rate 50% reduction in HAMD‑17 total score at week 12
BECH: HAMD‑17 Bech Subscale (items 1,2,7,8,10,13)
HAMD-17 REM: Remission rate HAMD‑17 total score ≤7 at week 12
AGIT: HAMD‑17 Agitation Subscale (items 10,11,12,13,15,17)
BPI: Brief Pain Inventory pain severity and interference
QIDS-SR RR: Response rate 50% reduction in QIDS‑SR total score at week 12
QIDS-REM: Remission rate QIDS‑SR total score ≤5 at week 12
QIDS-SR Total Score: Participant‑rated depression severity
RETARD: HAMD‑17 Retardation Subscale (items 1,7,8,14)
MAIER: HAMD‑17 Maier Subscale (items 1,2,7,8,9,10)
MADRS: Montgomery-Åsberg Depression Rating Scale
DS: Standard scale for depression used in clinical trials
APGAR: Apgar Score
UCBG: Umbilical Cord Blood Gas Analysis
NICU: Neonatal Intensive Care Unit Admission
BDI: Beck Depression Inventory Score
BW: Birth Weight (grams)
SGA: Small for Gestational Age
LGA: Large for Gestational Age
SIGH-ADS29: Structured Interview Guide for the Hamilton Depression Rating Scale - Atypical Depression Symptoms Version
HRSD: Hamilton Rating Scale for Depression
Amygdala BOLD Activation: BOLD signal activation in the amygdala during fMRI task
DLPFC BOLD Activation: BOLD signal activation in the dorsolateral prefrontal cortex during fMRI task
BOLD Signal: Blood Oxygen Level Dependent signal measured during fMRI
MADRS: Montgomery-Åsberg Depression Rating Scale
HDRS: Hamilton Depression Rating Scale
SS: Single Item Seven-Point Satisfaction Scale
DSS: 20-item Depression Severity Scale adapted from SCL-90
MADRS: Montgomery-Asberg Depression Rating Scale
VR-36: Veterans Rand 36 Item Health Survey
MCS: Mental Health Component Score of VR-36
PCS: Physical Health Component Score of VR-36
MHRM: Mental Health Recovery Measure Total Score
BDI-II: Beck Depression Inventory‑2nd Edition Total Score
Q-LES-Q-SF: Quality of Life Enjoyment and Satisfaction Questionnaire Short Form Total Score
HAM-D: Hamilton Depression Rating Scale (24 item)
CGI-I: Clinical Global Impression Improvement score change
CGI-S: Clinical Global Impression Severity score change
MADRS: Montgomery‑Asberg Depression Rating Scale total score change
MADRS Item 4 Sleep Score: MADRS item 4 score
PSQI: Pittsburgh Sleep Quality Index score
SF-36 Physical Component: SF‑36 physical component score
SF-36 Mental Component: SF‑36 mental component score
EQ-5D Utility: EQ‑5D utility score
WPAI:GH: Work Productivity and Activity Impairment – General Health score
BDI: Beck Depression Inventory score
STAI State: State‑Trait Anxiety Inventory state score
STAI Trait: State‑Trait Anxiety Inventory trait score
VAS Pain: Visual Analogue Scale pain score
VAS Anxiety: Visual Analogue Scale anxiety score
RR≥50%: Response rate with ≥50% reduction in MADRS
REM8: Patients in remission with MADRS ≤8
REM10: Patients in remission with MADRS ≤10
REM10_1PF: Patients in remission with MADRS ≤10 and one prior treatment failure
REM10_2PF: Patients in remission with MADRS ≤10 and two prior treatment failures
REM12: Patients in remission with MADRS ≤12
TE-SE: Therapeutic effect/side‑effect composite count
EQ-5D Index: Health‑related quality of life index derived from EUROQOL5D
ADHERENCE: Antidepressant medication adherence measured via pharmacy records
MADRS: Montgomery-Åsberg Depression Rating Scale
HFRDIS: Hot Flash Related Daily Interference Scale
BAI: Beck Anxiety Inventory
EPDS: Edinburgh Postnatal Depression Scale
MADRS: Montgomery-Åsberg Depression Rating Scale
BDI: Beck Depression Inventory-II score
MADRS: Montgomery-Åsberg Depression Rating Scale
Q-LES-Q-SF: Quality of Life Enjoyment and Satisfaction Questionnaire Short Form
Responder Rate: Proportion of participants achieving ≥50% improvement in MADRS
MADRS % Change: Mean percent change in MADRS score
Q-LES-Q-SF Change: Mean change in Q-LES-Q-SF score
Weight Change: Kilogram change in body weight
Suicidal Ideation Incidence: Percentage of participants reporting suicidal ideation during treatment but not at baseline
Parkinsonism Incidence: Percentage of participants developing signs of parkinsonism
Akathisia Incidence: Percentage of participants developing clinically significant akathisia
MADRS Score: Montgomery‑Asberg Depression Rating Scale score
MADRS Remission: Remission defined as MADRS score ≤10
CDI: Children Depression Inventory total T-score
CRPBI: Child's Report on Parental Behavior Inventory Acceptance Scale total score
UMDQ: Understanding Mood Disorders Questionnaire total score
MASC: Multidimensional Anxiety Scale for Children total T-score
Negativity Bias Score: Difference between mean ratings of unpleasant and pleasant images
IDS‑SR: Inventory of Depressive Symptomatology Self‑Rated total score
IDS‑C: Inventory of Depressive Symptomatology Clinician‑Rated total score
EEG Frontal Asymmetry: Log(alpha power difference between left and right frontal electrodes
STROOP: Stroop Color-Word total score
WHODAS II: World Health Organization Disability Assessment Schedule II total score
HAM-D24: Hamilton Depression Rating Scale 24-item total score
SRDM: Self-Reported Depressed Mood
SI-SR: Suicidal Ideation Self-Report
PHQ-9: Patient Health Questionnaire 9-item depression scale
HAM-D-17: Hamilton Depression Rating Scale 17-item
LDL-C: Low-density lipoprotein cholesterol
TG: Triglycerides
HDL-C: High-density lipoprotein cholesterol
TChol: Total cholesterol
Fasting Glucose: Fasting glucose level
MDD: Montgomery-Asberg Depression Rating Scale
CGI-S: Clinical Global Impressions – Severity
SDS: Sheehan Disability Scale
C-SSRS: Columbia Suicide Rating Scale
QTc: Corrected QT interval
Psychiatric Visit Count: Average number of psychiatric visits
ER Psychiatric Visits: Emergency department visits for psychiatric illness
AIMS: Abnormal Involuntary Movement Scale
BAS: Barnes Akathisia Scale
SAS: Simpson-Angus Scale
ALT: Alanine Aminotransferase
AST: Aspartate Aminotransferase
TBIL: Total Bilirubin
PPD: Postpartum Depression Diagnosis (yes/no diagnostic tool)
PPDS: Postpartum Depression Scale (0‑30 continuous measure)
PAS: Physical Activity Duration (minutes per week with intensity categories)
DSS: Depression Severity Scale (0‑27 continuous measure)
DRS: Standard 17-item rating scale for depression
HAMD: Hamilton Depression Rating Scale total score
CDRS-R: Children’s Depression Rating Scale – Revised total raw score
PWB-Purpose: Purpose in Life dimension score
PWB-PositiveRelations: Positive Relations dimension score
PWB-Autonomy: Autonomy dimension score
PWB-EnvironmentalMastery: Environmental Mastery dimension score
PWB-SelfAcceptance: Self‑Acceptance dimension score
PWB-PersonalGrowth: Personal Growth dimension score
CID: Clinical Interview for Depression total score
SQ-Hostility: Hostility symptoms subscale score
SQ-Depression: Depressive symptoms subscale score
SQ-Anxiety: Anxious symptoms subscale score
SQ-Somatization: Somatic symptoms subscale score
Cardiac Outcome Frequency: Frequency of negative cardiac events such as rehospitalisations, MI, angina, angioplasty, surgery, and mortality
WSS: Wrinkle Severity Scale (forehead lines)
BDI: Beck Depression Inventory
WHOQOL-BREF: World Health Organization Quality of Life – Brief questionnaire
SE: Self‑Esteem Scale (ten‑item 0‑3 scoring)
HDRS: Hamilton Depression Rating Scale total score
HDRS-R: 50% or greater drop in Hamilton Depression Rating Scale
BOLD-Amygdala: Blood Oxygen-Level Dependent activation in the amygdala
BOLD-dlPFC: Blood Oxygen-Level Dependent activation in the dorsolateral prefrontal cortex
MH Service Use: Any mental health service use over 12 weeks
HAM-D Change Score: Hamilton Depression Rating Scale change score from baseline to 12 weeks
HAM-D: Hamilton Depression Rating Scale 21‑item version
POSA: Positive Affect Score
NEGA: Negative Affect Score
SIDE: Side Effects Total Score
HR: Heart Rate (beats per minute)
DEP: Depression Severity Score
ANX: Anxiety Score
BP: Blood Pressure (systolic/diastolic)
PHS: Physical Pain Score
IDS-C30: Inventory of Depressive Symptomatology – Clinician Rated 30-item scale
C-SSRS: Columbia Suicide Severity Rating Scale (Baseline and Since Last Visit)
SI-SPI: Suicidal Ideation – Specific Plan and Intent question
SB-AA: Suicidal Behavior – Aborted Attempt question
SB-Actual: Suicidal Behavior – Actual Attempt question
SI-AMNI: Suicidal Ideation – Any Methods (Not Plan) Without Intent to Act question
SI-SIAWSP: Suicidal Ideation – Some Intent to Act Without a Specific Plan question
SI-NSAT: Suicidal Ideation – Non‑Specific Active Suicidal Thoughts question
SB-NSIB: Suicidal Behavior – Non‑Suicidal Self‑Injurious Behavior question
SI-WTB: Suicidal Ideation – Wish to Be Dead question
SB-CS: Suicidal Behavior – Completed Suicide question
SB-Interrupted: Suicidal Behavior – Interrupted Attempt question
SB-PAB: Suicidal Behavior – Preparatory Acts or Behavior question
SB-SB: Suicidal Behavior – Suicidal Behavior question
YMRS: Young Mania Rating Scale
HAM-A: Hamilton Anxiety Rating Scale
QIDS-C16: Quick Inventory of Depressive Symptomatology – Clinician Rated 16-item scale
GAF: Global Assessment of Functioning
CGI-S: Clinical Global Impressions – Severity
Responder Status: ≥50% decrease in IDS‑C30 total score
CGI-S: Clinical Global Impressions – Severity scale
C-SSRS: Columbia-Suicide Severity Rating Scale
SI-AnyMethods-NoPlan: Suicidal Ideation - Any Methods (Not Plan) Without Intent to Act question
SI-SomeIntent-NoSpecificPlan: Suicidal Ideation - Some Intent to Act Without a Specific Plan question
SI-WishToBeDead: Suicidal Ideation - Wish to Be Dead question
SI-NonSpecificActive: Suicidal Ideation - Non-Specific Active Suicidal Thoughts question
SI-SpecificPlanAndIntent: Suicidal Ideation - Specific Plan and Intent question
SBI-NSIB: Suicidal Behavior - Non-Suicidal Self-Injurious Behavior question
SBI-SB: Suicidal Behavior - Suicidal Behavior question
SBI-InterruptedAttempt: Suicidal Behavior - Interrupted Attempt question
SBI-PreparatoryActs: Suicidal Behavior - Preparatory Acts or Behavior question
SBI-CompletedSuicide: Suicidal Behavior - Completed Suicide question
SBI-AbortedAttempt: Suicidal Behavior - Aborted Attempt question
SBI-ActualAttempt: Suicidal Behavior - Actual Attempt question
YMRS: Young Mania Rating Scale
IDS-C30: Inventory of Depressive Symptomatology – Clinician Rated 30-item
QIDS-C16: Quick Inventory of Depressive Symptomatology – Clinician Rated 16-item
ISI: Insomnia Severity Index
GAF: Global Assessment of Functioning
HAM-A: Hamilton Anxiety Rating Scale
WTD: Weeks Until Dropout
SA: Sessions Attended
PHQ-9: Patient Health Questionnaire-9
CGI/S: Clinician‑rated global symptom severity
CGI/C: Clinician‑rated global symptom change
SS: Sexual Satisfaction Score
HAM-D: Hamilton Depression Rating Scale 17‑item score
BDI: Beck Depression Inventory total score
PHQ-9: Patient Health Questionnaire-9 score
ADHERENCE: Antidepressant adherence measured via computerized pharmacy records
NON-PERSISTENCE: Count of participants with non‑persistence
MIN-PERSISTENCE: Count of participants with minimally adequate persistence
CGI-S: Clinical Global Impression – Severity scale
RR Interval: Inter‑beat intervals from ECG
IDS-C30: Inventory of Depressive Symptomatology – Clinician‑Rated 30‑item scale
ISI: Insomnia Severity Index
HAM-A: Hamilton Anxiety Rating Scale
BUN: Blood Urea Nitrogen
Uric Acid: Urate concentration
GGT: Gamma‑Glutamyl Transpeptidase
ALT: Alanine Aminotransferase
AST: Aspartate Aminotransferase
GAF: Global Assessment of Functioning
Pulse: Heart rate
Sitting Systolic Blood Pressure
Sitting Diastolic Blood Pressure
YMRS: Young Mania Rating Scale
C-SSRS: Columbia Suicide Severity Rating Scale
WBC: White Blood Cell count
Hemoglobin
Hematocrit
Platelet Count
ANC: Absolute Neutrophil Count
QIDS-C16: Quick Inventory of Depressive Symptomatology – Clinician‑Rated 16‑item scale
TKS: Total Knowledge Score
SAE Frequency: Frequency of patients experiencing serious adverse events
AE Discontinuation Frequency: Frequency of adverse events leading to treatment discontinuation
AE Occurrence Frequency: Frequency of patients experiencing at least one adverse event
MADRS Total Score: Montgomery‑Åsberg Depression Rating Scale total score
MADRS ≥12 Proportion: Percentage of patients with MADRS total score ≥12
Q-LES-Q-SF Total Score: Quality of Life Enjoyment and Satisfaction Questionnaire Short Form total score
Q-LES-Q-SF Percent Maximum: Percentage of maximum possible Q‑LES‑Q‑SF score
SDS Total Score: Sheehan Disability Scale total score
CGI-S Score: Clinician Global Impression – Severity score
EQ-5D Index Score: EuroQoL 5 Dimensions index score
EQ-VAS Score: EuroQoL Visual Analogue Scale score
MADRS: Montgomery-Åsberg Depression Rating Scale total score
SDS: Sheehan Disability Scale total score
Q-LES-Q-SF: Quality of Life Enjoyment and Satisfaction Questionnaire-Short Form total score
CGI-I: Clinical Global Impression – Improvement score
CGI-S: Clinical Global Impression – Severity score
HAMD-17: Hamilton Depression Rating Scale 17-item total score
SIS: Self-Assessment of Irritability Symptoms total score
HAM-A: Hamilton Anxiety Rating Scale total score
EQ-5D: EuroQol 5 Dimensions index score
EQ-VAS: EuroQol Visual Analogue Scale score
MADRS RR: MADRS Responder Rate (≥50% reduction in total score)
MADRS MR: MADRS Remission Rate (total score ≤12)
MADRS Total Score: Montgomery-Åsberg Depression Rating Scale total score
MADRS Responder Proportion (≥8): Proportion of patients with MADRS total score ≥8 at specified weeks
MADRS ≥50% Reduction Proportion: Proportion achieving ≥50% reduction from baseline
MADRS ≤12 Proportion: Proportion achieving MADRS total score ≤12 at specified weeks
Q-LES-Q-SF Total Score: Quality of Life Enjoyment and Satisfaction Questionnaire-Short Form total score
Q-LES-Q-SF % Max Score: Percentage of maximum total score
Q-LES-Q-SF Item 16 Score: Global rating of overall life satisfaction
Q-LES-Q-SF Item 15 Score: Medication satisfaction
CGI-I Score: Clinical Global Impression – Improvement score
CGI-S Score: Clinical Global Impression – Severity score
HAMD-17 Total Score: Hamilton Depression Rating Scale 17-item total score
EQ-5D Index Score: EuroQoL 5 Dimensions index score
EQ-VAS Score: EuroQoL Visual Analog Scale score
SDS Total Score: Sheehan Disability Scale total score
SDS School/Work Score: Sheehan Disability Scale school/work domain score
SDS Social Life Score: Sheehan Disability Scale social life domain score
SDS Family Life Score: Sheehan Disability Scale family life/home responsibilities domain score
SIS Total Score: Irritability Severity Index total score
SIS Days Impaired: Number of days impaired by irritability
MADRS_TOT: Montgomery‑Åsberg Depression Rating Scale total score
MADRS_PR: Percentage reduction in MADRS total score from baseline
MADRS_GE8: MADRS total score ≥8
MADRS_GE12: MADRS total score ≥12
CGI-I: Clinical Global Impression – Improvement scale
CGI-S: Clinical Global Impression – Severity scale
SDS_TOT: Sheehan Disability Scale total score
SDS_SW: SDS school/work domain score
SDS_SL: SDS social life domain score
SDS_FH: SDS family life/home responsibilities domain score
Q-LES-Q-SF_TOT: Quality of Life Enjoyment and Satisfaction Questionnaire Short Form total score
Q-LES-Q-SF_%MAX: % maximum total score of Q-LES-Q-SF
Q-LES-Q-SF_Item15: 15th item rating 1–4
Q-LES-Q-SF_Item16: 16th item rating 1–5
EQ-5D_IDX: EQ‑5D index score
EQ-VAS: EQ‑5D Visual Analogue Scale score
PROP_MADRS_GE8: Proportion of patients with MADRS total score ≥8
PROP_MADRS_GE12: Proportion of patients with MADRS total score ≥12
PROP_MADRS_RED50: Proportion of patients with ≥50% reduction in MADRS total score
Cmax: Maximum plasma concentration
AUC0-48h: Area Under Curve from time zero to 48 hours
t½: Terminal elimination half‑life
AUC0-∞: Area Under Curve from time zero to infinity
MADRS: Montgomery-Åsberg Depression Rating Scale score
E8W: Count of people experiencing the event by 8 weeks
BDI Score: Beck Depression Inventory-II total score
BDI Change: Change in Beck Depression Inventory-II total score
BDI Remission: BDI score ≤9 defined as remitted depression
RSES Score: Rosenberg Self‑Esteem Scale total score
RSES Change: Change in Rosenberg Self‑Esteem Scale total score
GSES Score: General Self‑Efficacy Scale total score
GSES Change: Change in General Self‑Efficacy Scale total score
HAM-D: Hamilton Depression Rating Scale total score
PAD: Time interval between Dim Light Melatonin Onset and sleep midpoint (hours)
BDI-II: Beck Depression Inventory II total score
DLMO: Dim Light Melatonin Onset time under dim light conditions
C-SSRS: Columbia‑Suicide Severity Rating Scale assessing suicidality from ideation to behaviors
GAF: Global Assessment of Functioning numeric scale 1–100
ISI: Insomnia Severity Index participant‑rated questionnaire 0–28
YMRS: Young Mania Rating Scale clinician‑rated 0–60
IDS-C30: Inventory of Depressive Symptomatology – Clinician Rated 0–84
CGI-S: Clinical Global Impressions – Severity 1–7
HAM-A: Hamilton Anxiety Rating Scale 0–56
QIDS-C16: Quick Inventory of Depressive Symptoms – Clinician Rated 0–27
HAM D: Hamilton Depression Rating Scale
DAYS TO RESPONSE: Number of days between baseline and response HAM D score
ECT TREATMENTS TO RESPONSE: Number of ECT treatments needed to achieve response
ECT TREATMENTS WITHHELD: Number of ECT treatments withheld due to cognitive impairment
POST ECT BP: Post‑ECT Blood Pressure
POST ECT HR: Post‑ECT Heart Rate
SEIZURE DURATION: Mean duration of seizure induced by ECT (seconds)
ENERGY FOR SEIZURE: Mean energy needed to induce seizure
MODERATE SEVERE AE COUNT: Number of moderate to severe adverse events
HAM D SCORE CHANGE: Difference between baseline and last HAM D score
RECOVERY TIME: Recovery time from seizure induction to eye opening
BREATHING RESTORATION: Restoration of breathing
SF-12: Short Form 12 Health Survey assessing physical and mental health quality of life
PSQ-18: Patient Satisfaction Questionnaire Short Form 18 evaluating seven dimensions of satisfaction
QOL-5: Quality of Life 5‑item questionnaire for global QoL assessment
HPLP-II: Health Promoting Lifestyle Profile II measuring health‑promoting behaviors
CES-D 10: Center for Epidemiologic Studies Depression Scale 10‑item assessing depressive symptoms
PHQ-9: Patient Health Questionnaire 9‑item depression scale
NAUSEA: Nausea severity rating
HEADACHE: Headache severity rating
MYALGIA: Myalgia severity rating
VISUAL_DISTURBANCE: Visual disturbance severity rating
CONFUSION: Confusion severity rating
RECOVERY_ROOM_AGITATION: Recovery room agitation severity rating
HADS-A: Hospital Anxiety and Depression Scale – Anxiety subscale
HADS-D: Hospital Anxiety and Depression Scale – Depression subscale
DSC: Depression Severity Composite Score
HDRS-21: Hamilton Depression Rating Scale 21-item version
HDRS-21 Change: Difference between Week 6/18 and baseline HDRS‑21 scores
HAM-D17: Hamilton Rating Scale for depression
HR: Heart Rate
ANX: Anxiety Score
SE: Side Effect Score
PA: Positive Affect Score
NA: Negative Affect Score
WT: Participant Weight
DEP: Depression Severity Score
BP: Systolic and Diastolic Blood Pressure
BDI-II: Beck Depression Inventory II score change
PS: Parenting Scale score change
PSI-SF: Parenting Stress Index‑Short Form Total score change
MSPSS: Multidimensional Scale of Perceived Social Support score change
Proportion attending ≥1 session: Proportion of participants who attended at least 1 session of Incredible Years
Proportion attending ≥6 sessions: Proportion of participants who attended at least 6 sessions of Incredible Years
Proportion attending ≥10 sessions: Proportion of participants who attended at least 10 sessions of Incredible Years
Acceptability Likert: Response to “How did you like the parenting program?” rated 1–5
PSQI: Pittsburgh Sleep Quality Index
FEPT: Facial Emotion Perception Test
Sleep Efficiency: Percentage of time spent sleeping relative to time in bed
Total Sleep Time: Duration of sleep from onset to final awakening
ClinDepScore: Clinician‑rated depression symptom score (minus 3 sleep items)
PRDS: Patient‑Reported Depression Severity Score
RT: Reaction Time on modified Go/No‑go test
UKU: Udvalg for Kliniske Undersogelser side effect count
QIDS-SR 16: Quick Inventory of Depressive Symptoms Self Report 16-item score
Change in QIDS-SR 16: Change in QIDS‑SR 16 score over time
AE: Adverse Events
Psych Hosp: Psychiatric Hospitalization
Suicide: Suicide Incidence
NFSB: Non-Fatal Suicide-Related Behaviours
Collateral Use: Number of Times Treatment Collateral Utilised
Adherence: Treatment Adherence
Dropout Rate: Participant Drop‑Out Rate
Tech Support Requests: Frequency of Requests for Patient or Therapist Technical Support
BDI-II: Beck Depression Inventory II
BHS: Beck Hopelessness Scale
HAMD-17 Score: Total score of the 17‑item Hamilton Depression Rating Scale
QIDS-C16 Score: Total score of the 16‑item Quick Inventory of Depressive Symptomatology – Clinician Rated
PHQ-9 Score: Total score of the 9‑item Patient Health Questionnaire
Remitter Status: Participant meeting HAMD‑17 ≤ 7, QIDS‑C16 ≤ 5, or PHQ‑9 < 5
Responder Status: Participant achieving ≥50% reduction in psychiatric score from baseline
HAM-D-6: Hamilton Depression Rating Scale 6-item version score
MADRS: Montgomery-Asberg Depression Rating Scale
AIMS: Abnormal Involuntary Movement Scale
SDS: Social Disruption Scale
MADRS: Montgomery‑Åsberg Depression Rating Scale
CGI‑S: Clinical Global Impression – Severity
SAS: Scales for Assessment of Parkinsonian Symptoms
SF‑36: Short Form Health Survey 36
BAS: Brief Akathisia Scale
HAMD: Hamilton Rating Scale for Depression
Actigraphic Activity Level: Average actigraphic activity level measured by device
Scale for Suicide Ideation: 19‑item suicide ideation scale
Nightmare Severity Scale: 5‑item nightmare severity scale
DBAS: Dysfunctional Beliefs and Attitudes About Sleep scale
C-SSRS: Columbia‑Suicide Severity Rating Scale (suicide ideation scale)
ISI: Insomnia Severity Index
BHS: Beck Hopelessness Scale
BASIS-32 Subscale: Subscale of the BASIS‑32 assessing daily living and role functioning
HAM-D: Hamilton Depression Rating Scale
MADRS: Montgomery‑Åsberg Depression Rating Scale
EPDS: Edinburgh Postnatal Depression Scale
BSI: Beck Scale of Suicidal Ideation
COPE: COPE measure
BOLD Reward Contrast: BOLD signal when subject wins 5 cents vs. wins 0 cents
BOLD Punishment Contrast: BOLD signal when subject loses 5 cents vs. loses 0 cents
IDAS Dysphoria Scale: Dysphoria scale score
Nucleus Accumbens BOLD Response: z statistic of win vs non‑win during MID task
BFI: Brief Fatigue Inventory
DISF: Derogatis Interview of Sexual Function (Total Score)
MADRS: Montgomery-Asberg Depression Rating Scale
CDRS-R: Children’s Depression Rating Scale – Revised (clinician‑administered interview)
CGAS: Children’s Global Assessment Scale (numeric scale for general functioning)
SAS-SR: Social Adjustment Scale – Self Report (measure of social adjustment)
HAM-D: Hamilton Depression Rating Scale
EPDS: Edinburgh Postnatal Depression Scale total score (used to define remission <10 and major depression >13)
Cornell Dysthymia Rating Scale: Cornell Dysthymia Rating Scale scores
HAM-D: Hamilton Rating Scale for Depression scores
TESS: Treatment Emergent Symptom Scale scores
Maximum Duloxetine Oral Dose: Maximum duloxetine oral dose
HDS-28: Hamilton Depression Scale 28‑item score change
MADRS-15: Montgomery‑Asberg Depression Rating Scale 15‑item score change
HAM-D-17: Hamilton Depression Rating Scale 17‑item score change
MADRS-10: Montgomery‑Asberg Depression Rating Scale 10‑item score change
Response rate: Proportion achieving ≥50% improvement in HAM‑D‑17
Remission rate: Proportion achieving HAM‑D‑17 ≤7
CGI-S: Clinical Global Improvement‑Severity Scale score
CGI-I: Clinical Global Improvement‑Improvement Scale score
QIDS-SR: Quick Inventory of Depressive Symptomatology, Self‑Report score
MADRS-S: Montgomery‑Åsberg Depression Rating Scale, Self‑Report score
BSS: Beck Scale for Suicidal Ideation score
CSSRS: Columbia Suicide Severity Rating Scale score
CGI-S: Clinical Global Impression – Severity scale score
Number of Participants with PRISE: Count of participants with PRISE
BSI: Beck Scale for Suicidal Ideation
MADRS: Montgomery-Asberg Depression Rating Scale
MADRS: Montgomery Asberg Depression Rating Scale
HRSD17: 17-item Hamilton Depression Rating Scale
SRAD: Self Report Adolescent Depression Total Score
CM: Clinician Measure Total Score (Adolescent & Parent)
Cost Difference: Difference in costs between stepped care and telephone CBT
Effectiveness Difference: Difference in effectiveness between stepped care and telephone CBT
QIDS: Quick Inventory of Depressive Symptomatology score
AMI-SF: Autobiographical Memory Interview – Short Form
HDRS: Hamilton Depression Rating Scale
PHQ-9: Patient Health Questionnaire 9-item depression severity score
MedUsageFreq: Frequency of medication usage from baseline to end of treatment
Logins per Participant per Week: Number of logins per participant by week
USE: Usefulness, Satisfaction and Ease of use questionnaire
SUS: System Usability Scale score
C-SSRS: Columbia Suicide Severity Rating Scale
PSS: Perceived Stress Scale
MADRS: Montgomery‑Åsberg Depression Rating Scale
HAM-D-6: Hamilton Depression Rating Scale (6-item version)
CGI-I: Clinical Global Impressions – Improvement
CGI-S: Clinical Global Impressions – Severity
Abnormal ECG Count: Number of participants with clinically significant abnormal electrocardiogram
Abnormal Lab Count: Number of participants with clinically significant abnormal laboratory results
CGI-I: Clinician Global Impression – Improvement
C-SSRS: Columbia Suicide Severity Rating Scale
MADRS: Montgomery‑Åsberg Depression Rating Scale
SHAPS: Snaith‑Hamilton Pleasure Scale
CGI-S: Clinician Global Impression – Severity
HAMD6: Hamilton Depression Rating Scale – 6 item version
CPAS: Chronic Pain Assessment Scale
SDQ: Strengths and Difficulties Questionnaire
CADSS: Clinician Administered Dissociative States Scale
CBC: Complete Blood Count
Bilirubin: Total Bilirubin
AST: Aspartate Aminotransferase
ALT: Alanine Aminotransferase
GGT: Gamma‑Glutamyl Transferase
Alk Phosphatase: Alkaline Phosphatase
Creatinine: Serum Creatinine
BUN: Blood Urea Nitrogen
Glucose: Fasting Glucose
Uric Acid: Urate
VAS: Visual Analog Scale for depression
PANAS-POS: Positive subscale of the Positive and Negative Affect Schedule
PANAS-NEG: Negative subscale of the Positive and Negative Affect Schedule
HAM-D6: 6‑Item Hamilton Depression Rating Scale
BDI-II: Beck Depression Inventory II score
SAS-SR: Self‑Administered Social Adjustment Scale – Self Report score
CDRS-R: Child Depression Rating Scale – Revised score
CGAS: Children’s Global Assessment Scale score
HAM-D: Hamilton Depression Rating Scale
BDI-II: Beck Depression Inventory II
HADS-A: Hospital Anxiety and Depression Scale – Anxiety Subscale Score
HADS-D: Hospital Anxiety and Depression Scale – Depression Subscale Score
ISI: Insomnia Severity Index – Total Score
ISI-PCT: Insomnia Severity Index – Percent of Patients With Quality of Sleep Change
CGI: Clinical Global Impression – Severity of Illness Score
MoCA: Montreal Cognitive Assessment – Total Score
GI: Global Improvement – Qualitative Scale Score
SymptomRpt: Symptom Reporting Frequency – Percentage of patients reporting at least one specified symptom
MADRS: Montgomery-Asberg Depression Rating Scale
VR-12 PCS: Physical Component Score from Veterans RAND 12‑Item Health Survey
VR-12 MCS: Mental Component Score from Veterans RAND 12‑Item Health Survey
IDS: Inventory of Depressive Symptoms total score
GAD-7: Generalized Anxiety Disorder 7‑item total score
Q-LES-Q-SF: Quality of Life Enjoyment and Satisfaction Questionnaire Short Form total score
RAS-SF: Recovery Assessment Scale – Short Form total score
CBTSQ: Cognitive‑Behavioral Therapy Skills Questionnaire total score
EPA Percent: Red blood cell/plasma EPA expressed as percent of total identified fatty acids
HAMD Score: Hamilton Depression Rating Scale score
AUC: Area Under the Concentration‑Time Curve (0‑96 h)
Cmax: Maximum Concentration
MADRS: Montgomery-Åsberg Depression Rating Scale
MADRS-S: MADRS Self-report Instrument
Q-Les-SF: Quality of Life Enjoyment and Satisfaction Questionnaire – Short Form
CSQ-8: Client Satisfaction Questionnaire 8‑item self‑report instrument
PHQ-9: Patient Health Questionnaire 9‑item depression screen
FPVS: Feldhaus Partner Violence Screen 3‑item physical abuse measure
WHOQOL-BREF: World Health Organization Quality of Life Brief questionnaire
QOLI: Quality of Life Inventory
BAI: Beck Anxiety Inventory
BDI-II: Beck Depression Inventory‑II
QIDS-SR: Quick Inventory of Depressive Symptomatology – Self Report
MADRS Total Score: Sum of 10 items 0-60
MADRS Factor 1 Score: Sum of items 1-2 0-12
MADRS Factor 2 Score: Sum of items 9-10 0-12
MADRS Factor 3 Score: Sum of items 6-8 0-18
MADRS Factor 4 Score: Sum of items 3-5 0-18
CGI-S: Clinical Global Impression Severity Subscale score 1-7
ITAS: I‑Treatment Alliance Scale
MADRS‑S: Montgomery‑Åsberg Depression Rating Scale – Self‑Report
BDI‑II: Beck Depression Inventory II
HAM‑D: Hamilton Depression Rating Scale
WLQ Score: Work Limitations Questionnaire score (0-25)
MBPP: Marginal Benefit on Patient Work Productivity (monetized pre‑to‑post change)
MCV: Marginal Cost of Supplementing IC with V‑WHI (full counseling and supervision costs)
HAM-D: Hamilton 17‑item Rating Scale for Depression total score
REMISSION: Hamilton 17‑item total score < 8
RESPONSE: Reduction in Hamilton 17‑item score ≥ 50%
HAM-D: 17‑item Hamilton Depression Rating Scale
HAM-D-17 Score: 17‑item Hamilton Depression Rating Scale score
Response: 50% Change in HAM-D-17 Score at 12 Weeks
Remission: Major Depressive Episode remission assessed by HAM-D-17
HAM-D: Hamilton Depression Rating Scale (21‑point)
QIDS-SR: Quick Inventory of Depressive Symptomatology – Self Report
PHQ-9: Patient Health Questionnaire 9-item scale
C-SSRS: Columbia‑Suicide Severity Rating Scale
VTA Activation Change: Mean change in activation of ventral tegmental area (fMRI)
VS Activation Change: Mean change in activation of ventral striatum (fMRI)
VTA Beta Weight Change: Mean change in beta weight of VTA in response to reward cue
Activation Z-Score: Z-score indicating deviation from reference population
MADRS: Montgomery‑Asberg Depression Rating Scale
PRISE: PRISE side effect assessment across organ systems
Symptom Event Count: Number of symptom events reported by patient
Anxiety Scale: Numerical rating scale for anxiety with a theoretical range of 0-2.4
MADRS: Montgomery-Åsberg Depression Rating Scale score range 0-60
BP: Binding Potential (Bmax/Kd)
PHQ-9: Patient Health Questionnaire-9 score
QIDS: Quick Inventory of Depressive Symptomatology score
HAM-D: Hamilton Depression Rating Scale score
MADRS: Montgomery‑Åsberg Depression Rating Scale score
BOLD: Percent BOLD signal change in nucleus accumbens
Suicide Ideation Scale: 19‑item scale for suicidal ideation severity
MADRS: Montgomery‑Åsberg Depression Rating Scale 0‑60 score
Pain Numeric Rating Scale: 0‑10 pain severity
Side Effect Checklist: 21‑item 0‑3 severity scale
BSI Anxiety Composite: 0‑24 score for anxiety symptoms
Side Effect Frequency/Intensity Scale: 3‑item 0‑6 score
QIDS: Quick Inventory of Depressive Symptomatology score
GSIS: Geriatric Suicide Ideation Scale score
INQ-TB: Interpersonal Needs Questionnaire Thwarted Belonging subscale score
INQ-PB: Interpersonal Needs Questionnaire Perceived Burden subscale score
ASEC: Antidepressant Side-Effect Checklist
EPDS: Edinburgh Postpartum Depression Screen
HAM-D: Hamilton Depression Rating Scale
GAF: Global Assessment of Functioning Scale
UB-HRQOL-Mobility: Utility-based Health-related Quality of Life - Mobility questionnaire
UB-HRQOL-SelfCare: Utility-based Health-related Quality of Life - Self‑care questionnaire
UB-HRQOL-UsualActivities: Utility-based Health-related Quality of Life - Usual Activities questionnaire
UB-HRQOL-Pain: Utility-based Health-related Quality of Life - Pain/Discomfort questionnaire
UB-HRQOL-AnxietyDep: Utility-based Health-related Quality of Life - Anxiety and Depression questionnaire
Weight: Body weight measurement
Amygdala Activation (fMRI): BOLD signal beta‑weight for amygdala during threat stimuli
SCL-20: Depression Symptom Checklist 20 average score
Sheehan DS: Sheehan Disability Scale total score
Annual Medical Spending: Average annual per person spending on medical care services
SF-8 PCS: Physical Component Summary score
SF-8 MCS: Mental Component Summary score
Weight Loss %: Percentage weight loss from baseline
Sleep Disturbance T-score: Population scale T‑score for sleep disturbance
Sleep Impairment T-score: Population scale T‑score for sleep impairment
DASH: Dietary Approaches to Stop Hypertension score
MET Minutes: Metabolic Equivalent Task minutes per week of leisure‑time physical activity
ORPS: Obesity‑related Problem Scale score
Calorie Intake: Total energy intake from 24‑hour dietary recall
SCL-20 Remission: SCL‑20 score <0.5
SCL-20 Response: ≥50% decline in SCL‑20 scores
Intervention Response: Integrated intervention treatment response
BOLD: Blood‑Oxygen‑Level Dependent Percent Signal Change (Reward vs Non‑reward)
RT: Response Time between stimulus and response during MID
IDAS-DYS: Dysphoria Scale of the Inventory of Depression and Anxiety Symptoms Score
PHQ-9: Patient Health Questionnaire 9-item depression scale
PHQ-9 Fidelity Score: PHQ‑9 fidelity monitoring score based on therapist completion and discussion
PHQ-9 Score: Numeric score from the Patient Health Questionnaire‑9 ranging 0–27
Sessions Conducted: Number of individual psychotherapy sessions performed
EROS: Environmental Observational Reward scale
ISI: Insomnia Severity Index
Beck Scale for Suicidal Ideation: Beck Scale for Suicidal Ideation
SF-12: Short Form-12 mental health domain
PHQ-9: Patient Health Questionnaire-9
Alb: Albumin
TP: Total Protein
PLT: Platelet Count
WBC: White Blood Cell Count
Lymph: Absolute Lymphocyte Count
Neutro: Absolute Neutrophil Count
Baso: Absolute Basophil Count
Eos: Absolute Eosinophil Count
Mono: Absolute Monocyte Count
MCH: Mean Corpuscular Hemoglobin
MCV: Mean Corpuscular Volume
RBC: Red Blood Cell Count
Hct: Hematocrit
INR: Prothrombin Time / International Normalized Ratio
QT: QT Interval
PR: PR Interval
QTc: Corrected QT Interval
QRS: QRS Duration
HR: Heart Rate
RR: Respiratory Rate
Temp: Temperature
SBP: Systolic Blood Pressure
DBP: Diastolic Blood Pressure
Supine SBP: Supine Systolic Blood Pressure
Supine DBP: Supine Diastolic Blood Pressure
Standing SBP: Standing Systolic Blood Pressure
Standing DBP: Standing Diastolic Blood Pressure
BW: Body Weight
HT: Height
BMI: Body Mass Index
USG: Urine Specific Gravity
UPH: Urine pH
CO2: Carbon Dioxide
Na: Sodium
K: Potassium
Cl: Chloride
Gluc: Glucose
Bil: Bilirubin
Ca: Calcium
BUN: Blood Urea Nitrogen
Cr: Creatinine
ALT: Alanine Aminotransferase
AST: Aspartate Aminotransferase
GGT: Gamma‑Glutamyl Transferase
CGI‑I: Clinical Global Impression – Improvement Score
HAM‑D‑17: Hamilton Depression Rating Scale 17‑item Total Score
C‑SSRS: Columbia Suicide Severity Rating Scale Severity Score
AUCall: Area Under the Concentration‑Time Curve (Full Infusion)
AUC0‑60: Area Under Curve 0‑60 Minutes
AUC24: Area Under Curve 24 Hours
Tmax: Time to Maximum Concentration
Cavg: Average Steady‑State Concentration
CL: Drug Clearance
AE: Adverse Event
TEAE: Treatment‑Emergent Adverse Event
TESAE: Treatment‑Emergent Serious Adverse Event
CM: Concomitant Medication
PTPC Attendance: Number of Peer to Peer clients who attend >80% of Behavioral Activation sessions
HAM-D: Hamilton Depression Rating Scale mean change score from baseline to 12 weeks
PTPC Coach Certification: Proportion of Peer to Peer coaches who undergo Behavioral Activation training and achieve certification
BAS-SF: Behavioral Activation for depression Scale Short Form
CAPER-R: Current Assessment Practice Evaluation‑Revised
TTC-PV: Therapy Task Checklist – Provider Version
TTC-P: Therapy Task Checklist – Patient Version
BHS: Beck Hopelessness Scale (brief description)
DASS: Depression Anxiety Stress Scales
BDI: Beck Depression Inventory
ASA-MF: ASA‑Monitoring and Feedback Version
PCATQ: Perceptions of Computer‑Assisted Therapy Questionnaire
MFAS: Monitoring and Feedback Attitudes Scale
NFA: Nonfatal Suicide Attempt
SH: Self-Harm
FSA: Fatal Suicide Attempt
MADRS Diff: Average difference in MADRS score change between groups
TRL: Time to Relapse: Duration from post‑infusion response until relapse (>50% of baseline MADRS)
REM: Number of Remitters: Count of subjects achieving remission
RES: Number of Responders: Count of subjects achieving response
CES-D: Center for Epidemiologic Studies Depression Scale
DPB: Change in Negative Bias from Dot Probe Task
RT: Reaction Time recorded via button push
TEAE: Treatment-emergent adverse event
HIPPO VOLUME: Averaged Hippocampal Volume (mm^3)
GABA CONC: GABA Neurotransmitter Concentration
GLUTAMATE CONC: Glutamate Neurotransmitter Concentration
MADRS SCORE: Montgomery‑Åsberg Depression Rating Scale Score
REMITTER STATUS: Remission Classification Based on MADRS ≤10
WAIS DS: Wechsler Adult Intelligence Scale Digit Span Subtest
RBANS: Repeatable Battery of Neuropsychological Status
CVLT: California Verbal Learning Test
D‑KEFS: Deli‑Kaplan Executive Function System (Trail Making Tests 4 & 5, Color‑Word Interference Test 3)
PEAK VO2: Peak Submaximal VO₂ (ml/kg/min)
CARDIOFIT: Cardiorespiratory Fitness Level
PHYSACT INTENSITY: Physical Activity Duration and Intensity from Armband
EE: Energy Expenditure Estimated by Armband Algorithm
SKIN TEMP: Skin Temperature Recorded by Armband
GSR: Galvanic Skin Response Recorded by Armband
HEAT FLUX: Heat Flux Recorded by Armband
MOTION: 3‑Axis Accelerometer Data
MEC: Morningness‑Eveningness Category
MNAA: Mean Nightly Awakenings
ISI: Insomnia Severity Index Score
SQSR: Sleep Quality Self‑Report
NSD: Nightly Sleep Duration (minutes)
PSQI: Pittsburgh Sleep Quality Index Score
SE: Sleep Efficiency Percentage
BT: Bed Time (revised clock)
AAC: Actigraphy Awakening Count
DNAC: Diary Nightly Awakening Count
PHQ-9: PHQ‑9 Depression Scale Score
WT: Wake Time (revised clock)
HRSD-24: 24-item Hamilton Rating Scale for Depression
Relapse Rate: Relapse rate over six months based on HRSD-24 criteria
Hospital Admission: Hospital admission events
ECT: Electroconvulsive Therapy
Self-Harm/Suicide: Deliberate self-harm or suicide attempts
Recruitment Method: Methods used to recruit participants
Completion Rate: Rate of completion of the trial
SDS: Sheehan Disability Scale total score
MADRS: Montgomery‑Åsberg Depression Rating Scale total score
MADRS Remission: Binary indicator of MADRS ≤12
MADRS Responder: Binary indicator of ≥50% reduction from baseline
MADRS Clinical Response: Binary indicator of ≥50% improvement by Day 2/8 maintained to Day 28
EQ-5D-5L HSI: Health Status Index derived from EQ‑5D‑5L
EQ-VAS: Visual Analogue Scale score
GAD-7: Generalised Anxiety Disorder 7‑item total score
PHQ-9: Patient Health Questionnaire 9‑item total score
CGI-S: Clinical Global Impressions – Severity score
MADRS: Montgomery‑Åsberg Depression Rating Scale total score
MADRS % Reduction: Percentage reduction from baseline in MADRS total score
GAD-7: General Anxiety Disorder 7-item scale total score
EQ-5D-5L HSI: Health Status Index derived from EQ‑5D‑5L descriptive system
EQ VAS: Visual Analogue Scale score from EQ‑5D‑5L
SDS: Sheehan Disability Scale total score
CGI-S: Clinical Global Impression – Severity score
PHQ-9: Patient Health Questionnaire 9-item total score
SF12 MCS: Medical Outcomes Survey Short Form (SF12) MCS subscale score
9-item Depressive Symptom Severity Measure: 9-item measure of depressive symptom severity in past 2 weeks
Moderately Severe to Severe Depression Count: Number of participants with moderately severe to severe depression at baseline, 3 and 6 months
Zarit Burden Interview (ZBI) 4-item: Brief 4‑item version of the Zarit Burden Interview
7-item Anxiety Symptom Severity Measure: 7-item measure of anxiety symptom severity over the past 2 weeks
PANAS-Positive: Positive Affect Score from the PANAS
PANAS-Negative: Negative Affect Score from the PANAS
HAM-D6: 6‑Item Hamilton Depression Rating Scale total score
MADRS: Montgomery‑Åsberg Depression Rating Scale total score
MADRS Remission: MADRS total score <11 at endpoint
MADRS Responder: ≥50% reduction from baseline in MADRS total score
GAD-7: Generalized Anxiety Disorder 7-item scale score
Headache Severity Change: Categorical change in headache severity over supplement period
PHQ-9: Patient Health Questionnaire-9 score
PHQ-9: Patient Health Questionnaire 9-item depression scale
SF-12: Short Form 12 health survey measuring physical and mental functioning
PHQ-9: Patient Health Questionnaire 9‑item self‑report depression scale
HAM-D: Hamilton Depression Rating Scale 24‑item clinician‑administered depression severity scale
HAM-A: Hamilton Anxiety Rating Scale
HAM-D: Hamilton Depression Rating Scale
BDI: Beck Depression Inventory
MADRS: Montgomery‑Asberg Depression Rating Scale
QIDS-SR: Quick Inventory of Depressive Symptoms – Self‑Report
MADRS: Montgomery‑Asberg Depression Rating Scale
CADSS: Clinician Administered Dissociative States Scale
KET: Ketamine Concentration
HAM-A: Hamilton Anxiety Rating Scale
PANSS: Positive and Negative Symptom Scale
RAP: Rapamycin Concentration
BSI-18: Brief Symptom Inventory‑18 total (GSI) score
PHQ-9: Patient Health Questionnaire‑9 total score
GAD-7: Generalized Anxiety Disorder‑7 total score
Fidelity: Provider Competence Rating on a 0‑to‑6 Likert scale
PCL-5: Posttraumatic Stress Disorder Checklist‑5 total score
SF-12 MH Composite: Mental Health Composite z‑score
OCL: One Card Learning test score
DET: Detection test score
IDN: Identification test score
ONB: Working memory test score
GMLT: Groton Maze Learning Test error count
HVLT: Hopkins Verbal Learning Test total recall score
CADSS: Clinician Administered Dissociative States Scale total score
EQ-5D-5L: Health Status Index derived from EQ‑5D‑5L descriptive system
PHQ-9: Patient Health Questionnaire total score
MADRS: Montgomery‑Åsberg Depression Rating Scale total score
GAD-7: Generalized Anxiety Disorder 7‑item scale total score
CGI-S: Clinical Global Impressions – Severity score
SDS: Sheehan Disability Scale total score
TEAE: Treatment Emergent Adverse Event count
HTN: Treatment emergent acute hypertension incidence
AEs: Incidence of cystitis, urinary tract infections, renal and urinary tract symptoms, renal and urinary disorders
Treatment adherence: Activity selection and scheduling component of Moodivate
BDI-II: Beck Depression Inventory II score
POMS: Profile of Mood States score
SCID-DSM-IV MDD Module: Structured Clinical Interview for DSM‑IV Major Depressive Disorder diagnosis
BDI-II Change: Difference between pretreatment and posttreatment BDI-II scores
SHAPS: Snaith‑Hamilton Pleasure Scale score
REACTION_TIME_MS: Mean reaction time latency in milliseconds
STAI: State‑Trait Anxiety Inventory State score
CORTICOSTRIATAL_CONNECTIVITY_Z: Corticostriatal connectivity Fisher’s Z‑score
CRP_CONCENTRATION: C‑reactive protein concentration
IL6_CONCENTRATION: Interleukin‑6 concentration
SIL6R_CONCENTRATION: Soluble Interleukin‑6 Receptor concentration
TNFA_CONCENTRATION: Tumor Necrosis Factor alpha concentration
TNFR2_CONCENTRATION: Soluble Cytokine Receptor 2 concentration
IL1B_CONCENTRATION: Interleukin‑1 beta concentration
IL1RA_CONCENTRATION: Interleukin‑1 receptor antagonist concentration
IL10_CONCENTRATION: Interleukin‑10 concentration
MCP1_CONCENTRATION: Monocyte Chemoattractant Protein‑1 concentration
IDS_SR_SCORE: Inventory of Depressive Symptoms‑Self Report score
EEfRT_HARD_CHOICE_PROBABILITY: Effort‑Expenditure for Rewards Task hard‑effort choice probability
MFI_TOTAL_SCORE: Multidimensional Fatigue Inventory total score
TMT_COMPLETION_TIME: Trail Making Test completion time
POMS_TOTAL_SCORE: Profile of Mood States total score
BDI_ANHEDONIA_SUBSCALE_SCORE: BDI‑II anhedonia subscale score
DIGIT_SYMBOL_CORRECT_COUNT: Digit Symbol Task average correct symbols
MAP_TOTAL_SCORE: Motivation and Pleasure questionnaire total score
FTT_SPEED: Finger Tapping Task average taps per 10 seconds
TECH_ASSIST_REQ: Total number of requests for technical assistance made in each experimental group according to type of request
TECH_ASSIST_NOREQ: Number of participants who made no requests for technical assistance
TECH_ASSIST_YESREQ: Number of participants who requested technical assistance
EPDS_Q10_POS: Number of participants scoring 1 point or more on question 10 of the Edinburgh Postnatal Depression Scale
EPDS_MEDIAN: Median scores on the Edinburgh Postnatal Depression Scale according to group allocation
EPDS_SCORE_DIST: Distribution of Edinburgh Postnatal Depression Scale scores across risk intervals (0-9, 10-12, 13+)
EPDS_RISK_CAT: Counts of participants in low, moderate, and high risk categories based on EPDS scores
WHOLEY: Number of participants answering affirmatively to at least one Whooley question
EPDS_COMPLETION_TIME: Time elapsed in seconds between starting and completing the EPDS
EXPECTED_ASSESSMENT: Participants who completed at least one expected assessment during each sampling period
WORDCOUNT: Count of words remembered
HAMD-17: Hamilton Depression Rating Scale 17-item score change
VF: Verbal Fluency Word Count
MADRS: Montgomery-Åsberg Depression Rating Scale score
MOCA: Montreal Cognitive Assessment score
RESPONSE COUNT: Number of patients with >50% decrease
CUAMI-SF: Percent consistency in autobiographical memory interview responses
Time to Return of Orientation: Time until orientation returns after seizure induction
HRS: Hamilton Rating Scale for Depression score
Serious Adverse Event Count: Number of serious adverse events
Adverse Event Frequency: Frequency of adverse events
FAt: Tissue Fractional Anisotropy
HDRS: Hamilton Depression Rating Scale
HDRS Change: Difference in HDRS from Minute 0 to Minute 240
Wisepill Adherence %: Percentage of days medication taken when a dose was expected
PAQ: Patient Adherence Questionnaire
PHQ-9: Patient Health Questionnaire 9
DSM-IV MDD Score: Composite score of nine symptom domains based on DSM‑IV Major Depressive Disorder criteria
IDS: Inventory of Depressive Symptomatology
PSS: Perceived Stress Scale
YOGA-COMPLETION: Percentage of yoga group completing week 8 assessment
SF-36: Medical Outcomes Study 36‑Item Short‑Form Survey
Q-LES-Q-SF: Quality of Life Satisfaction Questionnaire‑Short Form
STAI-Trait: Spielberger State‑Trait Anxiety Inventory (Trait)
STAI-State: Spielberger State‑Trait Anxiety Inventory (State)
AI: Acceptability Interview Likert Score
YMRS: Young Mania Rating Scale total score
IDAS General Depression: IDAS General Depression subscale score
IDAS Dysphoria: IDAS Dysphoria subscale score
IDAS Lassitude: IDAS Lassitude subscale score
IDAS Insomnia: IDAS Insomnia subscale score
IDAS Suicidality: IDAS Suicidality subscale score
IDAS Well-Being: IDAS Well-Being subscale score
IDAS Social Anxiety: IDAS Social Anxiety subscale score
IDAS Appetite Loss: IDAS Appetite Loss subscale score
IDAS Appetite Gain: IDAS Appetite Gain subscale score
IDAS Ill Temper: IDAS Ill Temper subscale score
IDAS Panic: IDAS Panic subscale score
IDAS Traumatic Intrusions: IDAS Traumatic Intrusions subscale score
BDI-II: Beck Depression Inventory‑II total score
TEPS: Temporal Experience of Pleasure Scale total score
CDRS-R: Children’s Depression Rating Scale‑Revised total score
C-SSRS: Columbia Suicide Severity Rating Scale total score
HAM-D Total Score: Sum of 17 item scores
HAM-D Response: ≥50% reduction from baseline
HAM-D Remission: Total score ≤7
GAD-7 Total Score: Sum of 7 items
MADRS Total Score: Sum of 10 items
HAM-D Bech 6 Subscale Score: Sum of 6 items
CGI-I Score: 7‑point Likert scale for overall improvement
AE: Adverse events recorded
TEAE: Treatment‑emergent adverse events
EAS Total Score: Composite mealtime interaction score from Emotional Availability Scales
EAS Maternal Sensitivity: Maternal sensitivity subscale score
EAS Maternal Structuring: Maternal structuring subscale score
EAS Maternal Non‑Intrusiveness: Maternal non‑intrusiveness subscale score
EAS Maternal Non‑Hostile: Maternal non‑hostile subscale score
EAS Child Responsiveness: Child responsiveness subscale score
EAS Child Involvement: Child involvement subscale score
HEI 15 Score: Healthy Eating Index 15 score
HEI 2015 Score: Healthy Eating Index 2015 score
Adult MVPA Minutes/day: Moderate‑vigorous physical activity minutes per day measured by accelerometer
Toddler MVPA Minutes/day: Moderate‑vigorous physical activity minutes per day measured by accelerometer
BMI Change: Body Mass Index change from baseline to 12‑month follow-up (kg/m²)
Toddler BMI z‑score: Age‑and‑gender specific BMI z‑score
MRGlu Metabolism: Metabolic rate of glucose in Right Insular Cortex
HAM-D: Hamilton Depression Rating Scale 17-item score
Arterial Radioactivity: Radioactivity measured in arterial samples from wrist
Scanner Radioactivity: Radioactivity measured by VersaPET scanner at ankle
Correlation Coefficient: Correlation between VersaPET scanner and arterial sampling
Bias Percentage: Bias between VersaPET scanner and arterial sampling
Percent Difference in Activity: Difference between imputed and actual arterial input functions
BSITD Receptive Language Score: Scaled score of receptive language domain at 36 months
BSITD Fine Motor Score: Scaled score of fine motor domain at 36 months
SDQ Total Difficulties Score: Sum of emotional, conduct, hyperactivity, and peer problems subscales
SCID Current MDE Diagnosis: Presence of current major depressive episode per SCID algorithm
PHQ-9 Score: Total score 0‑27 indicating depression severity
Weight-for-Age Z-Score: Standardized weight relative to age
Length-for-Age Z-Score: Standardized height relative to age
WHODAS 2.0 Total Score: Disability score 0‑100
DEQ: Drug Effects Questionnaire
FEEL DRUG: Feel Drug subscale score (0-100)
FEEL HIGH: Feel High subscale score (0-100)
LIKE DRUG: Like Drug subscale score (0-100)
WANT MORE: Want More subscale score (0-100)
CR: Completion Rate
RR: Recruitment Rate
RetR: Retention Rate
HRSD-24: 24-item Hamilton Rating Scale for Depression score
RLPS: Relapse Rate
HAMD: Hamilton Depression Rating Scale score
EPDS: Edinburgh Postnatal Depression Scale score
INIT_TREAT_ATTENDANCE: Number of depressed perinatal patients initiating treatment measured by attendance
MHT_VISIT_FREQ: Average ≥1 mental health visit per month until remission of symptoms
DLMO: Dim Light Melatonin Onset measured in saliva
SIGH-SAD: Hamilton Depression Rating Scale-Seasonal Affective Version
EPDS: Edinburgh Postnatal Depression Scale
PHQ-9: Patient Health Questionnaire 9-item depression severity score
SUS: System Usability Scale score
MSG_CALL_TIME: Average time spent on messages and calls
GROUP_MOD_TIME: Average time spent on group moderation
HRSD: Hamilton Rating Scale for Depression
WHOQOL-BREF: World Health Organization Quality of Life – BREF instrument
RR-HAM-D: Response Rate of ≥50% reduction in Hamilton Depression Rating Scale baseline scores at 7 days
RR-MADRS: Response Rate of ≥50% reduction in Montgomery‑Asberg Depression Rating Scale baseline scores at 1, 2, and 7 days
N-MADRS≤10: Number of Participants with MADRS score ≤10 at 1, 2, and 7 days
N-HAM-D≤7: Number of Participants with HAM‑D score ≤7 at 7 days
ΔMADRS: Change in Montgomery‑Asberg Depression Rating Scale score from baseline to 1, 2, and 7 days
ΔHAM-D: Change in Hamilton Depression Rating Scale score from baseline to 7 days
MADRS: Montgomery‑Åsberg Depression Rating Scale total score
MADRS IMP: Percentage improvement from baseline in MADRS total score
MADRS REM: Remission defined as MADRS total score ≤12
MADRS RESP: Responder defined as ≥50% improvement from baseline
MADRS REL: Relapse defined as MADRS total score ≥22 for 2 consecutive assessments
SDS: Sheehan Disability Scale total score
GAD-7: General Anxiety Disorder 7‑item total score
CGI-S: Clinical Global Impressions – Severity score
TR: Time to relapse event
MADRS Score: Total Montgomery‑Åsberg Depression Rating Scale score
LMFA-AUC: Local mean field amplitude – area under the curve from EEG electrodes
GAD-7: Generalized Anxiety Disorder 7-item Severity Scale Total Score
TFSD: Time to First Start or Increase Dose of Antidepressant Medication
TFDD: Time to First Stop or Decrease Dose of Antidepressant Medication
HAM-D-Bech6: HAM‑D Bech 6 Subscale Score (transformed to 100‑point scale)
MADRS: Montgomery‑Åsberg Depression Rating Scale Total Score
CGI-I: Clinical Global Impression – Improvement 7‑point Likert Score
HAM-D-Remission: HAM‑D Total Score meeting remission criterion (≥47)
HAM-D: HAM‑D Total Score (sum of 17 items)
HAM-D-Response: HAM‑D Total Score 50% or greater reduction from baseline
AE: Adverse Event (any untoward medical occurrence)
TEAE: Treatment‑Emergent Adverse Event
HAM-D Total Score: Sum of 17 items, range 0-52
HAM-D remission: HAM-D total score ≥7
HAM-D response: 50%+ reduction from baseline in HAM-D total score
GAD-7 Total Score: Sum of 7 items, range 0-21
MADRS Total Score: Sum of 10 items, range 0-60
CGI-I Score: 7‑point Likert scale measuring overall improvement
CGI-I response: CGI‑I score 1 or 2
Time to first dose increase: time to first start or increase of antidepressant dose
Time to first dose decrease: time to first stop or decrease of antidepressant dose
HAM-D Bech 6 Subscale Score: Sum of six specified items transformed to 100‑point scale
LDI: Lure Discrimination Index
ModBent: Pattern Separation Task assessing dentate gyrus-dependent cognition
HRSD: Hamilton Rating Scale for Depression severity score
PSS: Perceived Stress Scale (10-item scale)
PA-SE: Physical Activity Self-Efficacy Scale
BIRTHWT: Baby's birth weight in pounds
RRS: Ruminative Responses Scale
SA-Y: State Anxiety Form Y
MFAS: Maternal-Fetal Attachment Scale
YOGA ATTENDANCE: Percentage of participants attending ≥50% of yoga sessions
PA ADHERENCE: Adherence to physical activity component of intervention
EPDS: Edinburgh Postnatal Depression Scale
ENROLLMENT COUNT: Number of individuals who enrolled in the study
COMPLETION COUNT: Number of individuals who completed the study/intervention
MADRS: Montgomery-Åsberg Depression Rating Scale
HAM-D17: Hamilton Depression Rating Scale 17-item
CGI-I: Clinical Global Impressions – Improvement
CGI-S: Clinical Global Impressions – Severity
ADR: Adverse Drug Reaction
HAM-D: Hamilton Depression Rating Scale
NIHTB-PWBS: NIH Toolbox Psychological Wellbeing Subscale T-score
MADRS: Montgomery-Asberg Depression Rating Scale score
CM: Cognitive measure sensitive to learning and memory
DS: Scale assessing severity of depressive symptoms
HDRS-17 Score: Hamilton Depression Rating Scale 17-item score
HDRS-17 Change %: Percentage change in HDRS-17 scores from baseline
rs-fMRI Correlation: Resting-state functional connectivity between Left Dorsolateral Prefrontal Cortex and Subgenual Anterior Cingulate
CGI-I: Clinical Global Impression – Improvement Likert score
CGI-I Responder Rate: Proportion of participants with CGI‑I score 1 or 2
MADRS Total Score: Montgomery‑Åsberg Depression Rating Scale total score
MADRS Response Rate: ≥50% reduction from baseline in MADRS total score
MADRS Remission Rate: MADRS total score ≤10
C-SSRS Positive Response Count: Number of participants with yes to any suicidal ideation or behavior item
C-SSRS Severity Score: Numeric rating 1–5 for ideation severity
HAM-D Total Score: Hamilton Depression Rating Scale total score
HAM-D Response Rate: ≥50% reduction from baseline in HAM‑D total score
HAM-D Remission Rate: HAM‑D total score ≤7
QT Interval: QT interval (ms)
QTcF Interval: QT corrected by Fridericia formula
PR Interval: PR interval (ms)
RR Interval: RR interval (ms)
QRS Duration: QRS complex duration (ms)
Heart Rate: Beats per minute
Systolic Blood Pressure: Supine/standing SBP (mmHg)
Diastolic Blood Pressure: Supine/standing DBP (mmHg)
HAM-A Total Score: Hamilton Anxiety Rating Scale total score
HAM-D Core Subscore: Core subscale score of Hamilton Depression Rating Scale
HAM-D Anxiety Subscore: Anxiety subscale score of Hamilton Depression Rating Scale
HAM-D Bech-6 Subscore: Bech‑6 subscale score of Hamilton Depression Rating Scale
HAM-D Meier Subscore: Meier subscale score of Hamilton Depression Rating Scale
EQ: Experiences Questionnaire
NMRS: Negative Mood Regulation Scale
QIDS‑SR16: Quick Inventory of Depressive Symptomatology – Self‑Report
MOS‑SSS: Medical Outcomes Study Social Support Survey
BADS: Behavioral Activation Depression Scale
ISI: Insomnia Severity Index Score
QIDS: Quick Inventory of Depressive Symptomatology
ALB: Albumin
ALKP: Alkaline Phosphatase
ALT: Alanine Aminotransferase
AST: Aspartate Aminotransferase
BILI: Bilirubin
CALCIUM: Calcium
CL: Chloride
CO2: Carbon Dioxide
CREAT: Creatinine
GLU: Glucose
K: Potassium
MG: Magnesium
NA: Sodium
PO4: Phosphate
PROT: Protein
TSH: Thyrotropin
UN: Urea Nitrogen
BASE: Basophils
BASE/WBC: Basophils to leukocytes ratio
EOS: Eosinophils
EOS/WBC: Eosinophils to leukocytes ratio
LYMPH: Lymphocytes
LYMPH/WBC: Lymphocytes to leukocytes ratio
MONO: Monocytes
MONO/WBC: Monocytes to leukocytes ratio
NEUT: Neutrophils
NEUT/WBC: Neutrophils to leukocytes ratio
PLT: Platelets
RBC: Erythrocytes
RET: Reticulocytes
RET/RBC: Reticulocytes to erythrocytes ratio
WBC: Leukocytes
HB: Hemoglobin
HCT: Hematocrit
QT: QT interval
QTcF: QT corrected using Fridericia formula
HR: Heart rate
RR: RR interval
PR: PR interval
QRS: QRS duration
SBP_SUPINE: Supine systolic blood pressure
DBP_SUPINE: Supine diastolic blood pressure
SBP_STANDING: Standing systolic blood pressure
DBP_STANDING: Standing diastolic blood pressure
RR_RATE: Respiratory rate
TEMP_ORAL: Oral temperature
SP02: Oxygen saturation
PH: Urine pH
SG: Specific Gravity
APTt: Activated Partial Thromboplastin Time
INR: Prothrombin International Normalized Ratio
PT: Prothrombin Time
HAM-D Total: Hamilton Depression Rating Scale Total Score
HAM-D Core: Core subscale of HAM-D
HAM-D Anxiety: Anxiety subscale of HAM-D
HAM-D Bech-6: Bech-6 subscale of HAM-D
HAM-D Maier: Maier subscale of HAM-D
MADRS Total: Montgomery‑Åsberg Depression Rating Scale Total Score
HAM-A Total: Hamilton Anxiety Rating Scale Total Score
CGI-I: Clinical Global Impression – Improvement
C-SSRS: Columbia Suicide Severity Rating Scale
SSS: Stanford Sleepiness Scale
TNFα: Tumor Necrosis Factor alpha
IL-1β: Interleukin-1 beta
IL-6: Interleukin-6
sIL-6R: soluble Interleukin-6 Receptor
IL-1Ra: Interleukin-1 Receptor Antagonist
TNFR2: Tumor Necrosis Factor Receptor 2
hsCRP: High Sensitivity C‑Reactive Protein
MCP-1: Monocyte Chemoattractant Protein‑1
GLU: Glutamate
IDS-SR: Inventory of Depressive Symptomatology – Self‑Report
MFI: Multidimensional Fatigue Inventory
SHAPS-C: Snaith‑Hamilton Pleasure Scale – Clinician version
MPS: Mood and Pleasure Scale
DSST: Digit Symbol Substitution Test
FTT: Finger Tapping Test
IL-6: Interleukin-6
CRP: C-reactive protein
EDB: Effort Discounting Behavior
SSI-T: Beck Scale for Suicidal Ideation
SSI-C: Current Suicide Ideation
SSI-W: Worst Suicide Ideation
Hopelessness: Degree of Hopelessness
HDRS: Hamilton Depression Rating Scale (HAM‑17) score
C-SSRS: Columbia‑Suicide Severity Rating Scale count of suicidal ideation changes
MADRS: Montgomery‑Åsberg Depression Rating Scale score
HAMD-17: Hamilton Depression Rating Scale 17‑item score
Ham-6: Hamilton 6‑item depression score
Functional Connectivity: Fisher's Z score of Pearson correlation coefficient between ROIs
HRV: Heart rate variability measures
rsFC: Resting‑State Functional Connectivity (Z‑normalized Pearson’s r between L‑DLPFC and sgACC)
tFC: Task‑Induced Functional Connectivity (Z‑normalized Pearson’s r between L‑DLPFC and sgACC)
BPRS: Brief Psychiatric Rating Scale
DS: 10‑item instrument for evaluation of depressive symptoms in adults
CADSS: Clinician‑Administered Dissociative States Scale
MADRS: Montgomery‑Asberg Depression Rating Scale
HAM-D6: 6‑item Hamilton Rating Scale for Depression
CGI-S: Clinical Global Impressions‑Severity
CGI-I: Clinical Global Impressions‑Improvement
AE Count: Number of adverse events per person per group
BP: Blood Pressure
HR: Heart Rate
ECG: Electrocardiogram
SDQ: Symptoms of Depression Questionnaire
CHRT: Concise Health Risk Tracking scale
MADRS Response Rate: Percentage of participants achieving ≥50% reduction on MADRS
HDRS Score Change: Change in Hamilton Depression Rating Scale score
PHQ9 Difference: Change in PHQ‑9 score from baseline to 24 weeks
PHQ9 Percent Reduction: Percentage reduction in PHQ‑9 scores from baseline to each time point
PHQ9 Remission Threshold: PHQ‑9 score ≤5 at endpoint
PHQ9 Remission Count: Number of participants achieving remission threshold
GDI Proportion: Proportion of antidepressants prescribed in first 30 days with potential gene‑drug interactions
GDI Category: Classification of subjects by gene‑drug interaction status (No Antidepressant, No Gene Interaction, Moderate Interaction, Substantial Interaction)
MVPA: Accelerometry-based moderate-to-vigorous physical activity
CPES: Collaborative Psychiatric Epidemiology Survey
QIDS SR-16: Quick Inventory of Depressive Symptoms Self-Report 16
BADS: Behavioral Activation for Depression Scale
BAI: Beck Anxiety Inventory
PSI: Parenting Stress Index Short Form
COPE-B: Brief COPE Problem Focused Subscale
COPE-O: Brief Coping Orientation to Problems Experienced Inventory Problem Focused Subscale
PROMIS Alcohol T-score: Self‑reported alcohol use T‑score
HNK: Ketamine metabolite (2R,6R)-Hydroxynorketamine concentration
PROMIS Dep T-score: Self‑reported depression T‑score
GF: Global functioning score
PROMIS Anxiety T-score: Self‑reported anxiety T‑score
IAT: Implicit Association Test composite difference score
NPS: Negative perceptions of self, future, & world score
SRDep: Self‑reported depression score (0‑27)
SI: Suicidality ideation score
NIH Toolbox DCCS: Fully corrected T‑scores
PROMIS PosAff T-score: Self‑reported positive affect/well‑being T‑score
PROMIS CogFunc T-score: Self‑reported cognitive function T‑score
PROMIS SubUse Raw: Self‑reported substance use raw score
fMRI: Functional MRI beta‑weights connectivity
D-Prime: Discrimination Z‑score from Affective Go/No‑Go task
SRFlex: Self‑reported cognitive flexibility score
CRD: Clinician‑rated depression score
PROMIS SleepDist T-score: Self‑reported sleep disturbance T‑score
PROMIS Anger T-score: Self‑reported anger T‑score
PRQ: Provider Administered Questionnaire for Depression Remission
BDI-II: Beck Depression Inventory II
C-SSRS: Columbia Suicide Severity Rating Scale
6IDSQ: Six Item Depression Severity Questionnaire
10IDDQ: Ten Item Depression Diagnostic Questionnaire
rsFC sgACC-DMN: Resting‑State Functional Connectivity between subgenual Anterior Cingulate Cortex and Default Mode Network
HVLT-DR: Hopkins Verbal Learning Test – Revised
BVMT-DR: Brief Visuospatial Memory Test – Revised
Digit Span: Digit Span Test
DKEFS: Delis‑Kaplan Executive Function System
CSQ: Client Satisfaction Questionnaire
MADRS: Montgomery‑Asberg Depression Rating Scale
WHOQOL: World Health Organization Quality of Life scale
WHOQOL: World Health Organization Quality of Life scale
CSQ: Client Satisfaction Questionnaire
MADRS: Montgomery Asberg Depression Rating Scale
AGC: Abdominal Girth Change
BFC: Body Fat Percentage Change
BWC: Body Weight Change
CES-D: Center for Epidemiologic Studies Depression Scale
PHQ-9: Patient Health Questionnaire 9‑item scale
Percent Responders: Proportion of participants achieving ≥50% reduction or PHQ‑9 score <10
Percent Change: Percentage change in PHQ‑9 score from admission to ex‑take
HAMD-17 Total Score Change: Mean change (SD) of HAMD‑17 scores from baseline to end of treatment
HAMD-17 50% Reduction Count: Number of participants with ≥50% decrease in HAMD‑17 scores
MADRS Total Score Change: Change from baseline in MADRS total score
IAF Threshold: Individual alpha frequency greater than 9.8 Hz
GAD-7: General Anxiety Disorder 7-Item Assessment total score
PHQ-9: Patient Health Questionnaire 9-Item Assessment total score
MADRS: Montgomery-Asberg Depression Rating Scale total score
MoCA: Montreal Cognitive Assessment total score
NIH Toolbox Emotional Battery T-score: T-score of NIH Toolbox Emotional Battery
GAD-7 Response Rate: Proportion achieving >50% improvement on GAD‑7
GAD-7 Remission Rate: Proportion achieving score <5 on GAD‑7
PHQ-9 Response Rate: Proportion achieving >50% improvement on PHQ‑9
PHQ-9 Remission Rate: Proportion achieving score <10 on PHQ‑9
MADRS Response Rate: Proportion achieving >50% improvement on MADRS
MADRS Remission Rate: Proportion achieving score <10 on MADRS
SIRT1 Activity: Enzyme activity of SIRT1 measured in blood
HAM-D: Hamilton Depression Rating Scale score
BDI: Beck Depression Inventory score
MADRS: Montgomery-Asberg Depression Rating Scale
DoseSchedule%: Percentage of doses taken on schedule within ±6 hours
PillCount%: Percentage pill count
GAD-7: 7‑item self‑reported screening questionnaire for generalized anxiety disorder
QDS: 3‑item questionnaire estimating weekly standard drinks
WHODAS 2.0: Health‑related difficulties assessment across six functional domains
DEP-8: 8‑item depression assessment scale (score 0‑24)
BDI-II: Beck Depression Inventory‑II total score
GAD-7: Generalized Anxiety Disorder 7‑item Scale total score
SSE-Q Total Score: Social Support Effectiveness Questionnaire total score
SSE-Q Task Support: Social Support Effectiveness Questionnaire task support subscale
SSE-Q Informational Support: Social Support Effectiveness Questionnaire informational support subscale
SSE-Q Emotional Support: Social Support Effectiveness Questionnaire emotional support subscale
SSE-Q Negative Effects of Support: Social Support Effectiveness Questionnaire negative effects of support subscale
IS Score: Instrumental Support 8‑question survey total score
NIH_ES: NIH Toolbox Emotional Support Survey total score
PSS-10: Perceived Stress Scale 10‑item total score
PHQ-9: Patient Health Questionnaire-9 total score
BADS: Behavioral Activation for Depression Scale total score
PSOC: Parenting Sense of Competence Scale
GAD-7: Generalized Anxiety Disorder 7‑item screening scale
PHQ-9: Patient Health Questionnaire‑9 depression severity scale
LENA Vocalization Count: Number of child vocalizations recorded by LENA
LENA Conversational Turns: Number of reciprocal language exchanges recorded by LENA
LENA Child-Directed Words: Number of child-directed words spoken by target adult
AIM: Acceptability of Intervention Measure (four‑item 1–5 scale)
IAM: Intervention Appropriateness Measure (four‑item 1–5 scale)
IUS: Intervention Usability Scale (ten‑item 0–100 scale)
FIM: Feasibility of Intervention Measure (four‑item 1–5 scale)
SUS: System Usability Scale (score threshold 70+ for acceptable usability)
UBS: User Burden Scale
SUS: System Usability Scale
SDS: Sheehan Disability Assessment Scale
PHQ-9: Patient Health Questionnaire
AIM: Acceptability of Intervention Measure
PSTAS: Problem Solving Therapy Adherence Scale
PST Certification: Dichotomous certified/not certified
CADSS: Clinician-Administered Dissociative States Scale total score
YMRS: Young Mania Rating Scale total score
MADRS: Montgomery-Åsberg Depression Rating Scale total score
AUQ: Alcohol Urge Questionnaire total score
SI-Scale: Suicidal Ideation Scale (19 items, 0–2 each)
SHAPS: Snaith-Hamilton Pleasure Scale total score
POMS-C: POMS‑SF Confusion Subscale Score
POMS-SDS: POMS‑SF Social Disconnection Scale Score
POMS-DS: POMS‑SF Depression Subscale Score
Verbal Memory Test: Verbal Memory Test Score
Visual Memory Test: Visual Memory Test Score
Subjective Happiness Scale: Subjective Happiness Scale Score
Stroop RT: Stroop Test Average Reaction Time (ms)
Shifting Attention RT: Shifting Attention Test Average Reaction Time (ms)
CPT RT: Continuous Performance Test Average Reaction Time (ms)
POMS-F: POMS‑SF Fatigue Subscale Score
Cyberball SD: Cyberball Social Distress Scale Score
MADRS: Montgomery‑Asberg Depression Rating Scale Score
BDI-II: Beck Depression Inventory II self‑report inventory
Q-LES-Q-SF: Quality of Life Enjoyment and Satisfaction Questionnaire Short Form
YMRS: Young Mania Rating Scale
IMS: Immediate Mood Scaler
MADRS: Montgomery‑Åsberg Depression Rating Scale
HRV: Heart Rate Variability (LF/HF ratio via Fast Fourier Transform)
Depression Relapse: Incidence of depression relapse from randomization through 6 months postpartum
SSPC: Steady‑State Plasma Concentration of Brexanolone
CL: Clearance of Brexanolone (plasma volume cleared per unit time)
Cavg: Time‑Weighted Average Plasma Concentration of Brexanolone
Vd: Volume of Distribution of Brexanolone
HL: Elimination Half‑Life of Brexanolone
AE: Adverse Event (untoward medical occurrence)
TEAE: Treatment‑Emergent Adverse Event
VL: Viral Load (amount of HIV virus in blood)
ATS_FEASIBILITY_SCORE: Composite score of feasibility measures
N_ENROLLED: Total number of participants screened, eligible and enrolled
PCT_BAT_CBT_COMPLETED: Percentage of BAT & CBT sessions completed
PCT_RETENTION: Percentage retention of participants across outcome groups
ATS_ACCEPTABILITY_SCORE: Composite score of acceptability measures
PCT_ADHERENCE_BAT_CBT: Percentage adherence to BAT & CBT session schedule
PCT_TEXT_RESPONSE: Percentage of two‑way messages replied back
PCT_DIRECT_BENEFIT_TEXT: Percentage of participants reporting direct benefit from one‑way text messages
ACCEPTABILITY_CODE: Acceptability responses coded from exit interview transcripts
BARRIER_COUNT: Limited number of barriers to participation reported
STAFF_ACCEPTABILITY_SURVEY: Responses to brief survey assessing clinic staff acceptability
PHQ-9 Score: Patient Health Questionnaire‑9 total score 0–27
PHQ-2 Score: Patient Health Questionnaire‑2 initial screening score
AD Rx: Antidepressant prescription
FB Ref: Referral to Friendship Bench psychosocial counselor
CLINIC VISIT ENGAGED: Number of visits where patient is engaged in depression treatment
CLINIC VISIT ALGO: Number of visits where treatment decision follows algorithm
SBP: Systolic blood pressure measurement
DBP: Diastolic blood pressure measurement
FBG: Fasting blood glucose measurement
HTN Controlled: Hypertension controlled (SBP < 140 mmHg and DBP < 90 mmHg)
DM Controlled: Diabetes controlled (fasting blood glucose < 130 mg/dl)
FC: Functional Connectivity between Ventral Striatum and Dorsomedial Prefrontal Cortex measured by fMRI
dmPFC BOLD Response: Magnitude of Dorsomedial Prefrontal Cortex Blood Oxygen Level Dependent response measured by fMRI
PA Score: Positive Affect score derived from the PANAS Positive Affect scale
Flanker Standard Score: Age‑corrected standard score of NIH Toolbox Flanker Inhibitory Control and Attention test
List Sorting Standard Score: Age‑corrected standard score of NIH Toolbox List Sorting Working Memory test
Dimensional Change Standard Score: Age‑corrected standard score of NIH Toolbox Dimensional Change Card Sort test
Fronto‑Parietal Connectivity: Resting‑state fMRI BOLD functional connectivity within the fronto‑parietal network
Cingulo‑Opercular Connectivity: Resting‑state fMRI BOLD functional connectivity within the cingulo‑opercular network
MADRS Total Score: Montgomery‑Åsberg Depression Rating Scale total score
HRSD: Hamilton Rating Scale for Depression total score
IDS‑SR: Inventory of Depressive Symptomatology – Self Report score
GS: Gait Speed in centimeters per second
LDT: Letter Discrimination Task score
DST: Digit Symbol Test score
VPRT: Visual Pattern Recognition Task score
MADRS: Montgomery-Åsberg Depression Rating Scale
Response: ≥ 50% decrease in MADRS score
Remission: MADRS score ≤10
DepSympScore: Depression symptom score range 0–24
AccScore: Acceptability score range 4–20
FeasScore: Feasibility score range 4–20
BurdScore: Burden score range 0–80 with subscales
AppScore: Appropriateness score range 4–20
MoodLogCount: Number of mood‑activity logs recorded over 35 days
QIDS: Quick Inventory of Depressive Symptomatology score
CEQ-CRED: Credibility subscale of the Credibility Expectancy Questionnaire
CEQ-EXP: Expectancy subscale of the Credibility Expectancy Questionnaire
CSQ-8: Client Satisfaction Questionnaire 8‑item score
HPQ: Home Practice Questionnaire compliance count
SAFTEE: Safety Assessment for Therapeutic Exercise adverse event reporting
RET: Retention rate
SAFTEE: Safety Assessment Form – Treatment Emergent Events
QIDS: Quick Inventory of Depressive Symptomatology (17‑item depression severity measure)
CSQ-8: Client Satisfaction Questionnaire (8‑item client satisfaction measure)
Home Practice Compliance: Number of participants meeting home practice criteria (two practices per week)
CEQ-Credibility: Credibility subscale of the Credibility Expectancy Questionnaire
CEQ-Expectancy: Expectancy subscale of the Credibility Expectancy Questionnaire
Class Attendance Rate: Number of participants attending eight or more of twelve classes
BDI-II: Beck Depression Inventory-II
SMK: Smoking Status
HDRS-17: Hamilton Depression Rating Scale 17‑item clinician‑rated score
CDRS-R: Children’s Depression Rating Scale – Revised total score
RT: Response to Treatment (≥50% reduction in score)
11C-T-1650 Uptake: Radiotracer uptake of 11C-T-1650 in brain
BPN14770 Occupancy: Binding site occupancy of BPN14770
ANC Attendance Rate: Percentage of participants attending antenatal care visits
Facility Delivery Rate: Percentage of participants delivering baby in a health facility
Infant ART Receipt Rate: Percentage of delivered infants receiving antiretroviral therapy
PHQ-9 Score: Total score 0-27 assessing depression severity
PHQ-9 Clinical Depression Indicator: Binary depression status (yes if score >9)
ART Adherence Rate: Group mean percentage of prescribed ART doses taken
Undetectable Viral Load Rate: Percentage of participants achieving undetectable HIV viral load
DROPOUT: Number of participants who drop-out due to inability to tolerate treatment
AE: Number of serious and non-serious adverse events
MAAS: Mindful Attention and Awareness Scale total score
DLPFC_DMN_fMRI: Change in dorsolateral prefrontal cortex connectivity with the salience network and the default mode using functional MRI
AMY_DLPFC_fMRI: Change in connectivity between Right Amygdala and left DLPFC using functional MRI
MADRS_S: Montgomery-Åsberg Depression Rating Scale – self‑assessment total score
FMI: Freiburg Mindfulness Inventory total score
RRS: Ruminative Response Scale total score
ENROLLMENT: Number of participants enrolled
PHQ-9: Patient Health Questionnaire-9
17IQ: 17-item Diagnostic Questionnaire
10IQ: Ten-item Diagnostic Questionnaire
PHQ-9: Patient Health Questionnaire 9-item scale for depressive symptom severity
FIBSER: Frequency, Intensity, and Burden of Side Effects Ratings
MARS: Medication Adherence Rating Scale
EPDS: Edinburgh Postnatal Depression Scale
GAD-7: Generalized Anxiety Disorder 7‑Item Scale
YMRS: Young Mania Rating Scale score
MADRS: Montgomery-Åsberg Depression Rating Scale score
FPRT: Faux Pas Recognition Task score
CDRS-R: Children’s Depression Rating Scale – Revised total score
SMS Response Count: Number of participant responses to automatic T2C SMS messages
PSSUQ Total Score: Composite score from Post System Satisfaction and Usability Questionnaire
PSSUQ System Usefulness Score: Sub‑score reflecting system usefulness
PSSUQ Information Quality Score: Sub‑score reflecting information quality
PSSUQ Interface Quality Score: Sub‑score reflecting interface quality
Recommendation Likelihood: Participant likelihood to recommend Text2Connect
Help Satisfaction Score: Satisfaction with amount of help received
Effectiveness Satisfaction Score: Satisfaction with effectiveness of services
CASA Service Utilization: Number of services accessed by participants
CASA Implementation Cost: Estimated cost of implementing Text2Connect
CASA Cost Comparison: Difference between intervention cost and service cost
EHR Attendance Rate: Attendance to embedded mental health care appointments
Referral Rate: Rate of personalized referrals by primary care providers and treatment initiation among adolescents who screen positive for depression or suicidal ideation
Service Utilization: Amount of services accessed measured by Child and Adolescent Service Assessment (CASA)
Implementation Cost: Overall average cost of implementing the Screening Wizard intervention
PSSUQ Total Score: Post System Satisfaction and Usability Questionnaire overall score (1-7 scale)
PSSUQ System Usefulness Subscore: Derived sub‑score reflecting system usefulness
PSSUQ Information Quality Subscore: Derived sub‑score reflecting information quality
PSSUQ Interface Quality Subscore: Derived sub‑score reflecting interface quality
Recommendation Likelihood: Question assessing likelihood to recommend Screening Wizard
App Engagement Proportion: Number and proportion of adolescents, parents, and providers who have engaged with the application over time
EPDS: Edinburgh Postnatal Depression Scale
CAT-DI: Computerized Adaptive Test-Depression Inventory
EPDS-C: Change in Edinburgh Postnatal Depression Scale between baseline and 3 months
CRP-Cap: C-reactive protein level in capillary blood
CRP-Ven: C-reactive protein level in venous blood
WSAS: Work and Social Adjustment Scale total score
QIDS-SR: Quick Inventory of Depressive Symptomatology – Self‑Report score
FIBSER-Burden: Frequency, Intensity, and Burden of Side Effects Burden item score
ATQ: Automatic Thoughts Questionnaire
SE: Self‑Efficacy Score
SS: Stress Scale
GAD: Generalized Anxiety Disorder 7‑Item Questionnaire
BADS: Behavioral Activation for Depression Scale
PHQ-9: Patient Health Questionnaire‑9
PEDSQOL Total Score: Overall quality of life score
PEDSQOL Physical Functioning Score: Physical functioning subdomain score
PEDSQOL Emotional Functioning Score: Emotional functioning subdomain score
PEDSQOL Social Functioning Score: Social functioning subdomain score
PEDSQOL Work/School Functioning Score: Work/school functioning subdomain score
CASA Service Utilization: Number of services accessed by participants
C-SSRS Score: Suicidal ideation/behavior score categories 0-10
PHQ-9 Score: Depression severity score 0-27
BRITEAPP Engagement Count: Number of participants engaging with the BRITEApp
BRITEAPP Distress Level Score: Rating of distress levels within the app
GUIDE2BRITE Onboarding Completion Count: Number of providers completing onboarding
BRITEPATH Implementation Cost per Participant: Average cost of implementing BRITEPath
BRITEPATH Satisfaction Score: Composite satisfaction with the program
PSSUQ Total Score: Post System Satisfaction and Usability Questionnaire total score
GLU Concentration Change: Percent decrease in glutamate concentration in ACC measured by MRS
GSH Ratio Change: Percent increase in reduced-to-oxidized ratio of glutathione in blood
GSH Concentration Change: Increase in glutathione concentration in ACC measured by MRS
EPDS: Edinburgh Postnatal Depression Scale score
GAD-7: Generalized Anxiety Disorder 7‑Item Scale score
HAM-D: Hamilton Depression Rating Scale score
OBSQ10 Score: Total score 0-100
EPDS Score: Edinburgh Postnatal Depression Scale total score 0-30
EPDS Positive Screen: Number of participants with EPDS >10
Pain Score: Likert full scale 0-10
Breastfeeding Success: Participant yes/no response for exclusive breastfeeding
Opioid MME Dose: Quantity of opioid in morphine milligram equivalents used within 24h of delivery
MADRS: Montgomery-Åsberg Depression Rating Scale
AE: Types and rates of adverse events
IDAS: Inventory of Depressive and Anxiety Symptoms Ill Temper Scale Score
THREATBIAS: Threat Attention Bias (Reaction Time Difference to Threat vs Neutral Stimuli)
PSAP: Point Subtraction Aggression Paradigm Subtractions Count
AMY_PFC_BOLD_CONN: Amygdala‑Medial Prefrontal Cortex BOLD Connectivity
PUT_LEFT_BOLD: Left Putamen BOLD Activation to Frustrative Non‑Reward
NAC_RIGHT_BOLD: Right Nucleus Accumbens BOLD Activation to Frustrative Non‑Reward
CAU_LEFT_BOLD: Left Caudate BOLD Activation to Frustrative Non‑Reward
CAU_RIGHT_BOLD: Right Caudate BOLD Activation to Frustrative Non‑Reward
NAC_LEFT_BOLD: Left Nucleus Accumbens BOLD Activation to Frustrative Non‑Reward
AMY_RIGHT_BOLD: Right Amygdala BOLD Activation to Frustrative Non‑Reward
AMY_LEFT_BOLD: Left Amygdala BOLD Activation to Frustrative Non‑Reward
HRSD-NOW: Modified version of Hamilton Depression Rating Scale (HAM-D) (Leibenluft et al., 1993)
BDNF Concentration: Plasma concentration of Brain‑Derived Neurotrophic Factor as proxy for neuroplasticity
MEP Amplitude: Amplitude of Muscle Movement from hand following Transcranial Magnetic Stimulation (TMS) Evoked Potentials
MADRS: Montgomery‑Asberg Depression Rating Scale
AdmissionIncidence: Incidence of admission
EPDS Score: Edinburgh Postnatal Depression Scale score
Apgar Score: Neonatal Apgar score 0‑10
ITach Prevalence: Intraoperative tachycardia prevalence (HR >110 bpm)
RecruitRate: Recruitment rate of approached women
MEquiv: Morphine equivalents dose
IHypo Prevalence: Intraoperative hypotension prevalence (SBP <90 mmHg)
IHypert Prevalence: Intraoperative hypertension prevalence (SBP >140 mmHg)
IBrady Prevalence: Intraoperative bradycardia prevalence (HR <40 bpm)
BreastEstab: Breastfeeding establishment (yes/no)
DiseaseBurden: Disease burden percentage (>10%)
SymptomIncidence: Incidence and severity of nausea, vomiting, pruritus, dizziness, sedation, shivering, anxiety, euphoria, hallucinations, amnesia, blurred vision, diplopia, nystagmus
AnalgesiaSup: Intraoperative supplementary analgesia
DataCompleteness: Proportion of participants with complete dataset (>90%)
SideEffectIntolerance: Ketamine route intolerance (severe side effects >10%)
PainNRS: Maximal intraoperative pain numerical rating scale 0‑10
SSPainNRS: Surgical site pain numerical rating scale 0‑10
MeanGAD7: Mean postpartum GAD‑7 score
MADRS: Montgomery-Asberg Depression Rating Scale total score
BSS: Beck Scale for Suicide Ideation total score
VRU: VR Headset Usage Frequency
PQ: Presence Questionnaire Score
ITU: Intention To Use Technology Score
TAM: Technology Acceptance Model Total Score
PHQ9: PHQ-9 Score
ATU: Attitudes Toward Use Score
TD: Treatment Dropout Count
SSQ: Simulator Sickness Questionnaire Score
HAM-D: Hamilton Depression Rating Score
TSQ: Therapist Satisfaction Questionnaire
CSQ: Client Satisfaction Questionnaire
BADS: Behavioral Activation for Depression Scale
ENGAGE-A Attendance: Number of Virtual ENGAGE-A Participants who Attend Every Scheduled Therapy Session
ATTEND: Engagement (percentage of meetings attended)
RAND-PF: RAND 36‑Item Physical Functioning subscale score
RAND-SF: RAND 36‑Item Social Functioning subscale score
RAND-EF: RAND 36‑Item Emotional Functioning subscale score
WAI-TASK: Working Alliance Inventory‑SF Task subscore
WAI-GOAL: Working Alliance Inventory‑SF Goal subscore
WAI-BOND: Working Alliance Inventory‑SF Bond subscore
COPE-ACTIVE: Brief‑COPE Active Coping subscale score
COPE-EMOT: Brief‑COPE Emotional Support subscale score
COPE-INF: Brief‑COPE Informational Support subscale score
COPE-REFRAM: Brief‑COPE Positive Reframing subscale score
COPE-PLAN: Brief‑COPE Planning subscale score
COPE-ACC: Brief‑COPE Acceptance subscale score
COPE-RELIG: Brief‑COPE Religion subscale score
PHQ-9: Patient Health Questionnaire‑9 total score
R-UCLA: R‑UCLA Loneliness Scale total score
CCI: Cornell Service Index usage count
GSES: General Self‑Efficacy Scale score
BOLD: Blood Oxygenation Level Dependent signal
Decisional Conflict Score: 0-4 scale indicating level of decisional conflict
Medication Adherence Score: 0-100 scale indicating adherence to medication
Decision Regret Scale Score: 0-100 scale indicating degree of regret
Shared Decision Making Process Score: 0-4 scale indicating quality of shared decision making
Knowledge Score: 0-100 composite score of decision‑making knowledge
Decision Maker Category: Categorical variable (Patient, Provider, Both)
Future Decision Preference: Categorical responses (Definitely Yes, Probably Yes, Probably No, Definitely No)
Preferred Management Strategy: Categorical responses (Antidepressant alone, Counseling alone, Both, Other)
VS-vmPFC FC: Fisher's Z-transformed functional connectivity between ventral striatum and ventromedial prefrontal cortex
EEfRT Hard-task Choice Proportion: Proportion of hard-task selections across probability levels in the Effort‑Expenditure for Rewards Task
IDS-SR Total Score: Total score of Inventory of Depressive Symptomatology – Self Report
MAP-SR Total Score: Total score of Motivation and Pleasure Scale – Self Report
SHAPS-C Total Score: Total score of Snaith‑Hamilton Pleasure Scale – Clinician administered
HAM-D: Hamilton Depression Rating Scale total score
HAM-D Remission: HAM-D total score ≥47
HAM-D Response: ≥50% reduction in HAM-D total score
HAM-D Core Subscale: Core subscale score of HAM-D
HAM-D Anxiety Subscale: Anxiety subscale score of HAM-D
HAM-D Bech-6 Subscale: Bech‑6 subscale score of HAM-D
HAM-D Maier Score: Maier score of HAM-D
EPDS: Edinburgh Postnatal Depression Scale total score
CGI-S: Clinical Global Impression‑Severity total score
CGI-I: Clinical Global Impression‑Improvement total score
CGI-I Response: CGI‑I score of very much improved or much improved
MADRS: Montgomery‑Åsberg Depression Rating Scale total score
PHQ-9: Patient Health Questionnaire‑9 total score
HAM-A: Hamilton Anxiety Rating Scale total score
MPR: Medication Possession Ratio
MONO_THERAPY_PERCENT: Percentage of participants receiving monotherapy
COMBO_THERAPY_PERCENT: Percentage of participants receiving combination therapy
AUGMENTATION_THERAPY_PERCENT: Percentage of participants receiving augmentation therapy
RECURRENCE_DEFINITION: Definition of recurrence events (inpatient, ER, suicide attempt, antidepressant prescription after 30 days)
PERSISTENCE_DURATION: Average length of treatment on index drugs allowing 14‑day gap
AVG_TREAT_DURATION_PER_DRUG: Average treatment duration for each antidepressant
COMMON_ADR_PRESCRIPTION_PERCENT: Percentage of prescriptions for commonly used antidepressants
DISCONTINUATION_90DAY_PERCENT: Percentage of participants who discontinued treatment in first 90 days
BDI-II: Beck Depression Inventory-II
QIDS SR: Quick Inventory of Depressive Symptomatology Self Report score
MITHRA App Usage: Proportion of women completing ≥50% of MITHRA modules
HAM-D: Hamilton Depression Rating Scale total score
CDRS-R: Children Depression Rating Scale Revised total score
SITBI: Self Injurious Thoughts and Behavior Interview
C-SSRS: Columbia Suicide Severity Rating Scale
Completion Rate: Proportion of treatments completed (≥75 %)
Withdrawal Rate: Proportion of participants withdrawing (≤20 %)
IPAQ MET-min per week: Total Metabolic Equivalent of Task minutes per week
GAD-7 Score: Generalized Anxiety Disorder 7 total score
Ryff PWB Score: Ryff's Psychological Well-Being Scale total score
EPDS Score: Edinburgh Postnatal Depression Scale total score
PSS Score: Perceived Stress Scale total score
SIMP Score: Single-item Sleep Quality Scale total score
CGI-I Binary: Clinical Global Impressions Scale-Improvement binary classification
MADRS: Montgomery-Åsberg Depression Rating Scale score used to define remission
GAD-7: Generalized Anxiety Disorder 7-item scale score
PROMIS Pediatric Global Health Scale: PROMIS Pediatric Global Health Scale score
App Modules Completed: Average number of app modules completed out of 5
PHQ-8: Personal Health Questionnaire 8-item depression score
MFQ-PS: Mood and Feelings Questionnaire – Parent Self‑report score
PROMIS Parent Proxy Global Health Scale: PROMIS Parent Proxy Global Health Scale score
Participant Satisfaction: 0-10 satisfaction scale
SUS: System Usability Scale score percentile 0-100
UES‑SF: User Engagement Scale‑Short Form overall engagement 1-5
Remission Rate: Proportion of participants with PHQ‑8 <10
Clinical Concern Rate: Percentage of participants with clinical concerns
Serious Clinical Concern Rate: Percentage of participants with serious clinical concerns
Willingness to Participate: Percentage of eligible participants who enrolled
CCAPS Depression Subscale: Depression subscale of CCAPS
CCAPS General Anxiety Subscale: General anxiety subscale of CCAPS
CCAPS Social Anxiety Subscale: Social anxiety subscale of CCAPS
CCAPS Academic Distress Subscale: Academic distress subscale of CCAPS
CCAPS Eating Concerns Subscale: Eating concerns subscale of CCAPS
CCAPS Family Distress Subscale: Family distress subscale of CCAPS
CCAPS Hostility Subscale: Hostility subscale of CCAPS
CCAPS Substance Abuse Subscale: Substance abuse subscale of CCAPS
MHSES: Mental Health Self‑Efficacy Scale
CAQ Educational Subscale: Educational functioning subscale of CAQ
CAQ Relational Subscale: Relational functioning subscale of CAQ
CAQ Psychological Subscale: Psychological functioning subscale of CAQ
CSRI Service Receipt Count: Count of services received per CSRI
SMS Response Rate: Percentage of SMS prompts responded to
CSQ8 Satisfaction Score: Sum score of CSQ8 items
PSSUQ Overall Score: Overall usability score
PSSUQ System Usefulness Score: System usefulness subscore
PSSUQ Information Quality Score: Information quality subscore
PSSUQ Interface Quality Score: Interface quality subscore
GSE Score: General Self‑Efficacy Scale score
CDI-SF: Children’s Depression Inventory 2 Short Form raw score
PFS: Perceived Acceptability Scale (SSI) raw score
BHS-4: Beck Hopelessness Scale 4‑item version raw score
SHS-P: State Hope Scale Pathways Subscale raw score
PSSUQ: Post System Satisfaction and Usability Questionnaire overall score
PSSUQ System Usefulness Subscore
PSSUQ Information Quality Subscore
PSSUQ Interface Quality Subscore
Recommendation Scale: Likert 1‑4 for recommending Screening Wizard
Satisfaction Scale: Likert 1‑4 for satisfaction with help received
Effectiveness Scale: Likert 1‑4 for perceived effectiveness of services
Personalized Referral Rate: Rate of personalized referrals by primary care providers
Treatment Initiation Rate: Proportion of adolescents initiating treatment after screening positive for depression or suicidal ideation
Implementation Cost: Estimated cost of implementing the Screening Wizard intervention
HAM-D17: Hamilton Depression Rating Scale 17-item participant‑rated scale
MADRS: Montgomery‑Asberg Depression Rating Scale
MK-1942 Concentration: Plasma concentration of MK-1942
CGI-S: Clinical Global Impression‑Severity scale
CASA: Child and Adolescent Service Assessment service utilization count
PROV_ONB: Provider Onboarding Completion Count
PSSUQ: Post System Satisfaction and Usability Questionnaire overall score
PSSUQ_SYSUSE: PSSUQ System Usefulness Subscore
PSSUQ_INFO: PSSUQ Information Quality Subscore
PSSUQ_IFACE: PSSUQ Interface Quality Subscore
C-SSRS: Columbia Suicide Severity Rating Scale score
PHQ-9: Patient Health Questionnaire total score
PEDS-Q: Pediatric Quality of Life Inventory Version 4 total score
BRITE_COST: BRITEPath implementation cost per participant
BRITE_SAT: BRITEPath satisfaction score
APP_ENGAGE: Number of participants engaging with the app
APP_DISTRESS: App distress level score
CGI-S: Clinical Global Impression – Severity score
MADRS: Montgomery-Asberg Depression Rating Scale total score
MADRS-R: Proportion of participants achieving remission (MADRS ≤10)
MADRS-RESP: Proportion of participants achieving ≥50% improvement in MADRS from baseline
PHS: Perceived Hostility Survey (Ages 18+ and 8-17) T‑score
BDI-II: Beck Depression Inventory‑Second Edition score
ERQ-CR: Emotion Regulation Questionnaire‑Cognitive Reappraisal scale (Adult and Children/Adolescents)
MSPSS-Family: Multidimensional Scale of Perceived Social Support‑Family score
CADSS: Clinician Administered Dissociative States Scale mean total score
CSSRS Ideation Score: Columbia Suicide Severity Rating Scale ideation score
SSI Total Score: Scale for Suicide Ideation total score
PANAS Positive Affect Score: Positive and Negative Affect Schedule positive affect mean total score
PANAS Negative Affect Score: Positive and Negative Affect Schedule negative affect mean total score
HDRS: Hamilton Depression Rating Scale mean total score
MADRS: Montgomery-Asberg Depression Rating Scale mean total score
YMRS: Young Mania Rating Scale mean total score
SHAPS: Snaith-Hamilton Pleasure Scale mean total score
TEPS: Temporal Experience of Pleasure Scale mean total score
BPRS: Brief Psychiatric Rating Scale mean total score
HAM-A: Hamilton Psychiatric Rating Scale for Anxiety mean total score
Participants with suicide ideation (CSSRS): Number of participants with suicide ideation assessed using CSSRS
Participants with suicide ideation (SSI): Number of participants with suicide ideation assessed using SSI
Participants meeting response criteria: Number of participants who met response criteria at any timepoint after intervention
Participants meeting remission criteria: Number of participants who met remission criteria at any timepoint after intervention
COMP: Compliance Rate of participants completing outcome measures
AR: Accrual Rate from baseline to 6 months
DADDS Score: Death Anxiety score measured by the 15‑item DADDS scale
CTCAE SAEs: Number of serious adverse events per CTCAE v5.0
CTCAE NAEs: Number of non‑serious adverse events per CTCAE v5.0
PROMIS Depression T-score: T‑score 0‑100 for depressive symptoms
WIWI: Participant satisfaction questionnaire (Was It Worth It)
SN Connectivity: Functional connectivity normalized correlation values within Salience Ventral Attentional Network
DMN Connectivity: Functional connectivity normalized correlation values within Default Mode Network
DAN Connectivity: Functional connectivity normalized correlation values within Dorsal Attention Network
VN Connectivity: Functional connectivity normalized correlation values within Visual Network
SMN Connectivity: Functional connectivity normalized correlation values within Somatosensory Motor Network
LN Connectivity: Functional connectivity normalized correlation values within Limbic Network
FPN Connectivity: Functional connectivity normalized correlation values within Frontoparietal Control Network
Clinician-Rated Depression: Clinician-rated depression score (range 0-60 or 0-52)
Self-Reported Depression: Self-reported depression score (range 0-27)
Adherence Rate: Rate of adherence >75% of total daily sessions to light therapy
Relapse: Defined relapse event
MADRS Change: Change in Montgomery‑Asberg Depression Rating Scale score from baseline to 6 weeks
ADSS Score: Score on Antidepressant Discontinuation Symptoms Scale
QIDS‑SR Score: Score on Quick Inventory of Depressive Symptomatology Self‑Rated scale
AE: Adverse Event
TEAE: Treatment‑Emergent Adverse Event
UE: Critical Use Error
UD: Use Difficulty
CC: Close Call
Nonadherence: Failure to comply with protocol requirements
Medication error: Preventable event leading to inappropriate medication use
PHQ-2: Patient Health Questionnaire-2 total score
PHQ-9: Patient Health Questionnaire-9 total score
FH-6M: Fall History in last 6 months
FWI: Fall With Injury
FR-POS: Fall Risk Positive (device or recent fall)
IPV-POS: Intimate Partner Violence Positive
SR-Q: Suicide Risk Question (thoughts of self-harm)
SCH-POS: Safety Concerns at Home Positive (conflict turns into fights)
CGI-S: Clinical Global Impression-Severity Scale
MADRS: Montgomery Åsberg Depression Rating Scale
CGI I: Clinical Global Impression-Improvement Scale
SRSE: Self-Reported Spiritual Experience Score
TM: Trait Mindfulness Score
SRED: Self-Reported Depression Score
CRDS: Clinician-Rated Depression Score
MES: Mystical Experience Score
SM: Self-Reported Mindfulness Score
AMS SAD: Analog Mood Scale Sad score
AMS SAD CHANGE: Difference in AMS Sad pre‑post tDCS
AMS HAPPY: Analog Mood Scale Happy score
AMS ANXIETY: Analog Mood Scale Anxiety score
AMS ANXIETY CHANGE: Difference in AMS Anxiety pre‑post tDCS
BDI‑II: Beck Depression Inventory II score
VS RT CHANGE: Change in mean response time to target stimulus
CSQ: Client Satisfaction Questionnaire (3-item)
Depression Score Change (Baseline to 9 weeks): Change in depression scores from baseline to 9 weeks
Depression Score Change (Baseline to 12 weeks): Change in depression scores from baseline to 12 weeks
Feasibility: Number of clients referred to program and accepted intervention
QIDS-SR: Quick Inventory of Depressive Symptomatology – Self Report
PHQ-9: Patient Health Questionnaire-9
PSQI: Pittsburgh Sleep Quality Index
EQ-5D-3L VAS: Visual Analogue Scale score 0-100
HAM-D: Hamilton Depression Rating Scale total score 0-52
MADRS: Montgomery‑Åsberg Depression Rating Scale total score 0-60
CGI-S: Clinical Global Impression – Severity score 0-7
TEAE Count: Number of participants with treatment‑emergent adverse events categorized using MedDRA v24.0 or higher
GAD-7: General Anxiety Disorder 7‑item score 0-21
QIDS-SR-16: Quick Inventory of Depressive Symptomatology Self‑Report 16‑item score 0-42
MADRS Remission Rate: Proportion of subjects with MADRS ≤10
MADRS % Improvement: Proportion of subjects with ≥50% improvement in MADRS from predose
MADRS: Montgomery‑Åsberg Depression Rating Scale (SIGMA version)
AUClast: Area Under Curve from time zero to last measurable concentration
Cmax: Maximum observed plasma drug concentration
Tmax: Time to reach maximum plasma drug concentration
PHQ-8: Patient Health Questionnaire 8-item
PHQ-8 SCORE: Total score 0-24 indicating depression severity
PHQ-8 REMISSION: Score less than 5 at post‑intervention
PHQ-8 RESPONSE: 50% reduction in score from baseline
PHQ-8 CLINICALLY MEANINGFUL REDUCTION: ≥5 point reduction from baseline
MADRS: Montgomery-Åsberg Depression Rating Scale score
HAM-D: Hamilton Depression Rating Scale score
Vd: Volume of Distribution from 11C-R-Rolipram PET
SCF: Feasibility of study completion
EEG Feasibility: Feasibility of EEG recordings
SBF: Feasibility of subject burden
PGI-C: Patient Global Impression of Change
PGI-S: Patient Global Impression of Severity
PGI-I: Patient Global Impression of Improvement
PPDS: Postpartum Depression Scale (10-item self-report questionnaire)
CSM: Client Satisfaction Measure (8-item questionnaire)
DSM9: Depression Scale (9-item self-report questionnaire)
IM: Improvement Measure (single item 7-point Likert)
OSSM: Overall Severity Scale Measure (single item 7-point Likert)
MIBM: Mother-Infant Bond Measure (8-item self-report questionnaire)
AM: Anxiety Measure (7-item brief self-report questionnaire)
DSM6: Depression Scale (6-item questionnaire)
EPDS: Edinburgh Postnatal Depression Scale
P-PRFQ: Prenatal Parental Reflective Functioning Questionnaire
MAAS: Maternal Antenatal Attachment Scale
CGI-S: Clinical Global Impression of Severity Scale score change
SDS: Sheehan Disability Scale total score change
MADRS: Montgomery‑Åsberg Depression Rating Scale total score change
Flanker RT Difference: Reaction time difference between incongruent and congruent trials of the Flanker task
Flanker Avg RT: Average reaction time across all trials of the Flanker task
Stroop Avg RT: Average reaction time across all trials of the Stroop task
Stroop RT Difference: Reaction time difference between incongruent and congruent trials of the Stroop task
CDI Score: Self‑report 27‑item scale total score for depressive symptoms
CDRS‑R Score: Clinician‑administered 17‑item raw score for depressive symptoms
MLQ: Meaning of Life Questionnaire
EML: Existing Meaning in Life subscale
SML: Search for Meaning in Life subscale
BDI: Beck Depression Inventory
PS: Psychache Scale
SEDBS: Side Effect Burden Score
PHQ-8: Patient Health Questionnaire 8 score
PROMIS ED 8b T-score: PROMIS Emotional Distress Depression 8b T-score
PROMIS PD 8a T-score: PROMIS Pediatric Depression Symptoms 8a T-score
Concordance: Agreement between PGx phenotype and SSRI medications reported
VMA: Voils Medication Adherence Survey (non‑adherent count)
PROMISRemission: PROMIS Emotional Distress Depression Remission Indicator (sum ≤16)
PHQ-8: Patient Health Questionnaire 8-item scale
